Oblong (OBLG) 10-Q 16 Nov 20 2020 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2020	Nov. 09, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	001-35376
Entity Registrant Name	OBLONG, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0312442
Entity Address, Address Line One	25587 Conifer Road
Entity Address, Address Line Two	Suite 105-231
Entity Address, City or Town	Conifer
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80433
City Area Code	303
Local Phone Number	640-3838
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	OBLG
Security Exchange Name	NYSEAMER
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Central Index Key	0000746210
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		6,285,558
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash	$ 2,670	$ 4,602
Accounts receivable, net	2,207	2,543
Inventory	1,126	1,816
Prepaid expenses and other current assets	725	965
Total current assets	6,728	9,926
Property and equipment, net	641	1,316
Goodwill	7,366	7,907
Intangibles, net	10,737	12,572
Operating lease - right of use asset, net	1,665	3,117
Other assets	105	71
Total assets	27,242	34,909
Current liabilities:
Current portion of long-term debt, net of discount	4,942	2,664
Accounts payable	662	647
Accrued expenses and other current liabilities	1,489	1,752
Deferred revenue	1,973	1,901
Current portion of operating lease liabilities	907	1,294
Total current liabilities	9,973	8,258
Long-term liabilities:
Long-term debt, net of current portion and net of discount	3,035	2,843
Operating lease liabilities, net of current portion	889	2,020
Other long-term liabilities	0	3
Total long-term liabilities	3,924	4,866
Total liabilities	13,897	13,124
Commitments and contingencies (see Note 13)
Stockholders’ equity:
Common stock, $.0001 par value; 150,000,000 shares authorized; 5,355,841 shares issued and 5,242,558 outstanding at September 30, 2020 and 5,266,828 shares issued and 5,161,543 outstanding at December 31, 2019	1	1
Treasury stock, 113,283 and 105,285 shares of common stock at September 30, 2020 and December 31, 2019, respectively	(181)	(165)
Additional paid-in capital	207,558	207,383
Accumulated deficit	(194,033)	(185,434)
Total stockholders’ equity	13,345	21,785
Total liabilities and stockholders’ equity	27,242	34,909
Series A-2 Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series C Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series D Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series E Preferred Stock
Stockholders’ equity:
Preferred stock	$ 0	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Preferred stock, convertible, shares authorized (in shares)	5,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	5,355,841	5,266,828
Common stock, shares outstanding (in shares)	5,242,558	5,161,543
Treasury stock, shares (in shares)	113,283	105,285
Series A-2 Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, stated value	$ 7,500	$ 7,500
Preferred stock, convertible, shares authorized (in shares)	7,500	7,500
Preferred stock, convertible, shares issued (in shares)	45	32
Preferred stock, convertible, shares outstanding (in shares)	45	32
Preferred stock, convertible, liquidation value	$ 338,000
Series C Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, stated value	$ 1,000	$ 1,000
Preferred stock, convertible, shares authorized (in shares)	1,750	1,750
Preferred stock, convertible, shares issued (in shares)	250	475
Preferred stock, convertible, shares outstanding (in shares)	250	475
Preferred stock, convertible, liquidation value	$ 250,000
Series D Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, stated value	$ 28.50	$ 28.50
Preferred stock, convertible, shares authorized (in shares)	1,750,000	1,750,000
Preferred stock, convertible, shares issued (in shares)	1,702,010	1,734,901
Preferred stock, convertible, shares outstanding (in shares)	1,702,010	1,734,901
Preferred stock, convertible, liquidation value	$ 48,507,000
Series E Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, stated value	$ 28.50	$ 28.50
Preferred stock, convertible, shares authorized (in shares)	175,000	175,000
Preferred stock, convertible, shares issued (in shares)	131,579	131,579
Preferred stock, convertible, shares outstanding (in shares)	131,579	131,579
Preferred stock, convertible, liquidation value	$ 3,750,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenue	$ 3,266	$ 2,370	$ 11,410	$ 7,403
Cost of revenue (exclusive of depreciation and amortization)	1,612	1,582	5,684	4,901
Gross profit	1,654	788	5,726	2,502
Operating expenses:
Research and development	747	190	3,062	652
Sales and marketing	668	38	2,708	111
General and administrative	1,332	1,035	5,173	2,917
Impairment charges	117	20	667	473
Depreciation and amortization	780	145	2,392	461
Total operating expenses	3,644	1,428	14,002	4,614
Loss from operations	(1,990)	(640)	(8,276)	(2,112)
Interest and other expense, net	102	0	322	1
Foreign exchange loss (gain)	(7)	0	0	0
Interest and other expense, net	95	0	322	1
Net loss	(2,085)	(640)	(8,598)	(2,113)
Preferred stock dividends	4	4	12	23
Net loss attributable to common stockholders	$ (2,089)	$ (644)	$ (8,610)	$ (2,136)
Net loss attributable to common stockholders per share:
Basic and diluted net loss per share (in dollars per share)	$ (0.40)	$ (0.12)	$ (1.64)	$ (0.42)
Weighted-average number of shares of common stock:
Basic and diluted (in shares)	5,237	5,184	5,257	5,128

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Series A-2 Preferred Stock	Series D Preferred Stock	Preferred StockSeries A-2 Preferred Stock	Preferred StockSeries B Preferred Stock	Preferred StockSeries C Preferred Stock	Preferred StockSeries D Preferred Stock	Preferred StockSeries E Preferred Stock	Common Stock	Common StockSeries C Preferred Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2018				32	75	525			5,113,726		132,519
Beginning Balance, value at Dec. 31, 2018	$ 6,830			$ 0	$ 0	$ 0			$ 1		$ (496)	$ 184,998	$ (177,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(598)												(598)
Stock-based compensation	29											29
Issuance of stock on vested restricted stock units (in shares)									16,824
Preferred stock conversion (in shares)					75	50			43,402
Preferred stock dividends	(15)											(15)
Purchase of treasury stock (in shares)											900
Purchase of treasury stock	(1)										$ (1)
Ending Balance (in shares) at Mar. 31, 2019				32	0	475			5,173,952		133,419
Ending Balance, value at Mar. 31, 2019	6,245			$ 0	$ 0	$ 0			$ 1		$ (497)	185,012	(178,271)
Beginning Balance (in shares) at Dec. 31, 2018				32	75	525			5,113,726		132,519
Beginning Balance, value at Dec. 31, 2018	6,830			$ 0	$ 0	$ 0			$ 1		$ (496)	184,998	(177,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,113)
Ending Balance (in shares) at Sep. 30, 2019				32	0	475			5,238,952		98,419
Ending Balance, value at Sep. 30, 2019	4,710			$ 0	$ 0	$ 0			$ 1		$ (165)	184,660	(179,786)
Beginning Balance (in shares) at Dec. 31, 2018				32	75	525			5,113,726		132,519
Beginning Balance, value at Dec. 31, 2018	$ 6,830			$ 0	$ 0	$ 0			$ 1		$ (496)	184,998	(177,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock conversion (in shares)						50				16,667
Forfeited restricted stock (in shares)	(10,063)
Ending Balance (in shares) at Dec. 31, 2019				32		475	1,734,901	131,579	5,266,828		105,285
Ending Balance, value at Dec. 31, 2019	$ 21,785			$ 0		$ 0	$ 0	$ 0	$ 1		$ (165)	207,383	(185,434)
Beginning Balance (in shares) at Mar. 31, 2019				32	0	475			5,173,952		133,419
Beginning Balance, value at Mar. 31, 2019	6,245			$ 0	$ 0	$ 0			$ 1		$ (497)	185,012	(178,271)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(875)												(875)
Stock-based compensation	24											24
Issuance of stock on vested restricted stock units (in shares)											(75,000)
Issuance of stock on vested restricted stock units											$ 382	(382)
Preferred stock dividends	(4)											(4)
Purchase of treasury stock (in shares)											24,000
Purchase of treasury stock	(34)										$ (34)
Ending Balance (in shares) at Jun. 30, 2019				32	0	475			5,173,952		82,419
Ending Balance, value at Jun. 30, 2019	5,356			$ 0	$ 0	$ 0			$ 1		$ (149)	184,650	(179,146)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(640)												(640)
Stock-based compensation	14											14
Issuance of stock on vested restricted stock units (in shares)									65,000
Preferred stock dividends	(4)											(4)
Purchase of treasury stock (in shares)											16,000
Purchase of treasury stock	(16)										$ (16)
Ending Balance (in shares) at Sep. 30, 2019				32	0	475			5,238,952		98,419
Ending Balance, value at Sep. 30, 2019	4,710			$ 0	$ 0	$ 0			$ 1		$ (165)	184,660	(179,786)
Beginning Balance (in shares) at Dec. 31, 2019				32		475	1,734,901	131,579	5,266,828		105,285
Beginning Balance, value at Dec. 31, 2019	21,785			$ 0		$ 0	$ 0	$ 0	$ 1		$ (165)	207,383	(185,434)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,129)												(3,129)
Stock-based compensation	32											32
Preferred stock conversion (in shares)						150			50,000
Forfeited restricted stock (in shares)							(14,441)
Preferred stock dividends	(4)											(4)
Issuance of preferred stock for accrued dividends (in shares)				13
Issuance of preferred stock for accrued dividends	98											98
Purchase of treasury stock	(7)										$ (7)
Ending Balance (in shares) at Mar. 31, 2020				45		325	1,720,460	131,579	5,316,828		105,285
Ending Balance, value at Mar. 31, 2020	18,775			$ 0		$ 0	$ 0	$ 0	$ 1		$ (172)	207,509	(188,563)
Beginning Balance (in shares) at Dec. 31, 2019				32		475	1,734,901	131,579	5,266,828		105,285
Beginning Balance, value at Dec. 31, 2019	21,785			$ 0		$ 0	$ 0	$ 0	$ 1		$ (165)	207,383	(185,434)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(8,598)
Preferred stock conversion (in shares)		13	1,686,659			225				75,000
Ending Balance (in shares) at Sep. 30, 2020				45		250	1,702,010	131,579	5,355,841		113,283
Ending Balance, value at Sep. 30, 2020	13,345			$ 0		$ 0	$ 0	$ 0	$ 1		$ (181)	207,558	(194,033)
Beginning Balance (in shares) at Mar. 31, 2020				45		325	1,720,460	131,579	5,316,828		105,285
Beginning Balance, value at Mar. 31, 2020	18,775			$ 0		$ 0	$ 0	$ 0	$ 1		$ (172)	207,509	(188,563)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,385)												(3,385)
Stock-based compensation	29											29
Issuance of stock on vested restricted stock units (in shares)									23,334
Forfeited restricted stock (in shares)							(17,364)
Preferred stock dividends	(4)											(4)
Issuance of preferred stock for accrued dividends	1											1
Purchase of treasury stock (in shares)											7,998
Purchase of treasury stock	(9)										$ (9)
Ending Balance (in shares) at Jun. 30, 2020				0		325	1,703,096	131,579	5,340,162		113,283
Ending Balance, value at Jun. 30, 2020	15,407			$ 0		$ 0	$ 0	$ 0	$ 1		$ (181)	207,535	(191,948)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,085)												(2,085)
Stock-based compensation	27											27
Preferred stock conversion (in shares)						75			25,000
Forfeited restricted stock (in shares)							(1,086)		(9,321)
Preferred stock dividends	(4)											(4)
Ending Balance (in shares) at Sep. 30, 2020				45		250	1,702,010	131,579	5,355,841		113,283
Ending Balance, value at Sep. 30, 2020	$ 13,345			$ 0		$ 0	$ 0	$ 0	$ 1		$ (181)	$ 207,558	$ (194,033)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss	$ (8,598)	$ (2,113)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,392	461
Bad debt expense	14	12
Amortization of debt discount	53	0
Amortization of right of use asset	834	37
Payments on lease liability	(895)	(43)
Stock-based compensation	89	67
Loss on foreign currency remeasurement	0	1
Change in inventory	0	0
Impairment charges - property and equipment	126	20
Impairment charges - goodwill	541	453
Changes in operating assets and liabilities:
Accounts receivable	322	270
Inventory	689	0
Prepaid expenses and other current assets	240	171
Other assets	(32)	25
Accounts payable	15	202
Accrued expenses and other current liabilities	(184)	(219)
Deferred revenue	72	(12)
Other liabilities	(3)	0
Net cash used in operating activities	(4,325)	(668)
Cash flows from investing activities:
Purchases of property and equipment	(8)	(17)
Net cash used in investing activities	(8)	(17)
Cash flows from financing activities:
Proceeds from PPP Loan	2,417	0
Purchase of treasury stock	(16)	(51)
Net cash provided by (used in) financing activities	2,401	(51)
Decrease in cash and cash equivalents	(1,932)	(736)
Cash at beginning of period	4,602	2,007
Cash at end of period	2,670	1,271
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	159	0
Non-cash investing and financing activities:
Issuance preferred stock in exchange for accrued dividends	99	0
Accrued preferred stock dividends	12	23
Issuance of common stock for vested restricted stock units	$ 0	$ 382

Business Description and Signif

Business Description and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Business Description and Significant Accounting Policies	Note 1 - Business Description and Significant Accounting Policies Business Description Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”) was formed as a Delaware corporation in May 2000 and is a provider of patented multi-stream collaboration technologies and managed services for video collaboration and network applications. Prior to March 6, 2020, Oblong, Inc. was named Glowpoint, Inc. (“Glowpoint”). On March 6, 2020, Glowpoint changed its name to Oblong, Inc. On October 1, 2019, the Company closed an acquisition of all of the outstanding equity interest of Oblong Industries, Inc., a privately held Delaware corporation founded in 2006 (“Oblong Industries” and, such transaction, the “Acquisition”); see further discussion in Note 3 - Oblong Industries Acquisition. In this Report, we use the terms “Oblong” or “we” or “us” or the “Company” to refer to (i) Oblong (formerly Glowpoint), for periods prior to the closing of the Acquisition, and (ii) the “combined organization” of Oblong (formerly Glowpoint) and Oblong Industries for periods after the closing of the Acquisition. For purposes of segment reporting, we refer to the Oblong (formerly Glowpoint) business as “Glowpoint” herein, and to the Oblong Industries business as “Oblong Industries” herein. Basis of Presentation The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2019. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The December 31, 2019 year-end condensed consolidated balance sheet data in this document was derived from audited consolidated financial statements. These condensed consolidated financial statements and notes included in this quarterly report on Form 10-Q does not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2019 and notes thereto included in the Company's fiscal 2019 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on May 15, 2020 (the “2019 10-K”). The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. Because the closing of the Acquisition of Oblong Industries occurred on October 1, 2019, the Company’s condensed consolidated financial statements for the three and nine months ended September 30, 2019 included in this Report do not reflect Oblong Industries’ financial results. Principles of Consolidation The condensed consolidated financial statements include the accounts of Oblong and our 100%-owned subsidiaries, (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, (ii) Oblong Industries, and (iii) the following subsidiaries of Oblong Industries: Oblong Industries Europe, S.L. and Oblong Europe Limited. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries. Segments Prior to the Acquisition of Oblong Industries on October 1, 2019, the Company operated in one segment. Following October 1, 2019, the former businesses of Glowpoint and Oblong Industries have been managed separately and involve different products and services. Accordingly, the Company currently operates in two segments: 1) the Glowpoint (now named Oblong) business, which includes managed services for video collaboration and network applications, and 2) the Oblong Industries business, which includes products and services for visual collaboration technologies. See Note 12 - Segment Reporting for further discussion. Use of Estimates Preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability of property and equipment, and intangible assets, the inputs used in the fair value of equity based awards as well as the values ascribed to assets acquired and liabilities assumed in the business combination. Significant Accounting Policies The significant accounting policies used in preparation of these condensed consolidated financial statements are disclosed in our 2019 10-K. Property and Equipment Property and equipment are stated at cost and are depreciated over the estimated useful lives of the related assets, which range from three to ten years. Leasehold improvements are amortized over the shorter of either the asset’s useful life or the related lease term. Depreciation is computed on the straight-line method for financial reporting purposes. During the three and nine months ended September 30, 2020, the Company recorded asset impairment charges on property and equipment of $117,000 and $126,000, respectively, for the discontinued use of, or disposal of, property and equipment. These charges are included in “Impairment Charges” on our condensed consolidated statement of operations. The impairment charges related to property and equipment for the three and nine months ended September 30, 2019 were $20,000. Leases The Company determines if an arrangement is a lease at inception. For the Company’s operating leases, the right-of-use (“ROU”) assets represents the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Since all of the lease agreements do not provide an implicit rate, the Company estimated an incremental borrowing rate in determining the present value of the lease payments. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectations regarding the terms. Variable lease costs such as operating costs and property taxes are expensed as incurred. Treasury Stock Purchases and sales of treasury stock are accounted for using the cost method. Under this method, shares acquired are recorded at the acquisition price directly to the treasury stock account. Upon sale, the treasury stock account is reduced by the original acquisition price of the shares and any difference is recorded in equity, on a first-in first-out basis. The Company does not recognize a gain or loss to income from the purchase and sale of treasury stock. Recently Issued Accounting Pronouncements In June 2016 the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326),” which was subsequently amended in February 2020 by ASU 2020-02 “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842).” Topic 326 introduces an impairment model that is based on expected credit losses,

Liquidity and Going Concern Unc

Liquidity and Going Concern Uncertainty	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity and Going Concern Uncertainty	Note 2 - Liquidity and Going Concern Uncertainty As of September 30, 2020, we had $2,670,000 of cash, $5,609,000 of total obligations under the Silicon Valley Bank (“SVB”) Loan Agreement, obligations of $2,417,000 under the Paycheck Protection Program loan, and a working capital deficit of $3,245,000. For the nine months ended September 30, 2020, we incurred a net loss of $8,598,000 and used $4,325,000 of net cash in operating activities. During the nine months ended September 30, 2020, we received cash proceeds of $2,417,000 from a loan made to the Company by MidFirst Bank under the Paycheck Protection Program (PPP) contained within the Coronavirus Aid Relief, and Economic Security (CARES) Act (the “PPP Loan”). See further discussion of the PPP Loan in Note 8 - Debt. As of September 30, 2020, the SVB Loan Agreement provided that interest-only payments were due through September 30, 2020, after which monthly principal payments of $291,500, plus interest, were payable in order to fully repay the loan by March 1, 2022. Subsequent to the period of this Report, in October 2020, the Company: (i) completed a private placement of common stock for gross proceeds of $2,973,000, and (ii) completed an agreement with SVB to satisfy all outstanding obligations of $5,609,000 under the SVB Loan Agreement in exchange for a one-time cash payment of $2,500,000. See further discussion of these transactions in Note 14 - Subsequent Events. Our capital requirements in the future will continue to depend on numerous factors, including the timing and amount of revenue for the combined organization, customer renewal rates and the timing of collection of outstanding accounts receivable, in each case particularly as it relates to the combined organization’s major customers, the expense to deliver services, expense for sales and marketing, expense for research and development, capital expenditures, the cost involved in protecting intellectual property rights, the amount of forgiveness of the PPP Loan, if any, and any debt service obligations under the PPP Loan. While our Acquisition of Oblong Industries does provide additional revenues to the Company, the cost to further develop and commercialize its product offerings is expected to exceed its revenues for the foreseeable future. However, we have achieved certain cost synergies in connection with combining Glowpoint and Oblong Industries; we reduced the total of general and administrative, research and development, sales, and marketing expenses by $1,813,000, or 40%, from the first quarter of 2020 as compared to the third quarter of 2020 (or a total of $4,560,000 in the first quarter of 2020 as compared to $2,747,000 in the third quarter of 2020). We also expect to continue to invest in product development and sales and marketing expenses with the goal of growing the Company’s revenue in the future. The Company believes that, based on the combined organization’s current projection of revenue, expenses, capital expenditures, debt service obligations, and cash flows, it will not have sufficient resources to fund its operations for the next twelve months following the filing of this Report. We believe additional capital will be required to fund operations and provide growth capital including investments in technology, product development and sales and marketing. To access capital to fund operations or provide growth capital, we will need to raise capital in one or more debt and/or equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company. The factors discussed above raise substantial doubt as to our ability to continue as a going concern. The accompanying condensed consolidated financial statements do not include any adjustments that might result from these uncertainties. See Note 13 - Commitments and Contingencies to our condensed consolidated financial statements for discussion regarding certain additional factors that could impact the Company’s liquidity in the future.

Oblong Industries Acquisition

Oblong Industries Acquisition	9 Months Ended
	Sep. 30, 2020
Business Combinations [Abstract]
Oblong Industries Acquisition	Note 3 - Oblong Industries Acquisition On October 1, 2019 (the “Closing Date”), the Company closed its Acquisition of Oblong Industries, Inc. The Acquisition was consummated through the merger of Glowpoint Merger Sub II, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (the “Merger Sub”), with and into Oblong Industries on the Closing Date, with Oblong Industries continuing as the surviving corporation and as a wholly-owned subsidiary of the Company. The Acquisition was accounted for in accordance with FASB Accounting Standards Codification (“ASC”) Topic 805 “Business Combinations” (“ASC 805”) as a business combination, which requires an allocation of the purchase price of an acquired entity to the assets acquired and liabilities assumed based on their estimated fair values at the date of Acquisition. The purchase price and the fair value of the assets acquired and liabilities assumed were based on management estimates and values with assistance from an outside appraisal. Pursuant to ASC 805, the purchase price of $18,862,000 was measured as the fair value of the consideration exchanged in the Acquisition. The Company acquired net assets of $11,496,000, including $12,780,000 of identifiable intangible assets, in the Acquisition. The purchase price exceeded the fair value of the net assets acquired by $7,366,000, which was recorded as goodwill. The accompanying condensed consolidated financial statements do not include any revenues or expenses related to the Oblong Industries business on or prior to October 1, 2019 (the Closing Date of the Acquisition). The condensed consolidated statements of operations for the three and nine months ended September 30, 2020 include $1,942,000 and $6,669,000 of revenue, respectively, and net losses of $334,000 and $3,839,000, respectively, related to Oblong Industries. The Company's unaudited pro forma results for the three and nine months ended September 30, 2019 are summarized in the table below, assuming the Acquisition had occurred on January 1, 2019. These unaudited pro forma results have been prepared for comparative purposes only and do not purport to be indicative of the results of operations which would have actually resulted had the Acquisition occurred on January 1, 2019, nor to be indicative of future results of operations. Pro forma and unaudited (as if the Acquisition of Oblong Industries had occurred on January 1, 2019) Three Months Ended September 30, 2019 Nine Months Ended September 30, 2019 ($ in thousands) ($ in thousands) Revenue Glowpoint $ 2,370 $ 7,403 Oblong Industries $ 4,259 $ 12,758 Pro forma total revenue $ 6,629 $ 20,161 Net loss Glowpoint $ 640 $ 2,113 Oblong Industries $ 3,756 $ 12,782 Pro forma net loss $ 4,396 $ 14,895

Inventory

Inventory	9 Months Ended
	Sep. 30, 2020
Inventory Disclosure [Abstract]
Inventory	Note 4 - Inventory Inventory was $1,126,000 and $1,816,000 as of September 30, 2020 and December 31, 2019, respectively, and consisted primarily of equipment related to our Mezzanine™ product offerings

Goodwill

Goodwill	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Note 5 - Goodwill As of September 30, 2020 and December 31, 2019, goodwill was $7,366,000 and $7,907,000, respectively. As of September 30, 2020, goodwill was comprised of $7,366,000 recorded in connection with the October 1, 2019 Acquisition of Oblong Industries. As of December 31, 2019, goodwill was comprised of (i) $7,366,000 recorded in connection with the October 1, 2019 Acquisition of Oblong Industries and (ii) $541,000 related to the Glowpoint reporting unit as discussed below. We test goodwill for impairment on an annual basis on September 30 of each year, or more frequently if events occur or circumstances change indicating that the fair value of the goodwill may be below its carrying amount. Following the Acquisition of Oblong Industries, the Company operated two reporting units, Glowpoint and Oblong Industries. During the nine months ended September 30, 2020, we considered the novel Coronavirus (COVID-19) pandemic and resulting declines in certain of the Company’s revenue to be a triggering event for an interim goodwill impairment test for both reporting units as of March 31. To determine the fair value of each reporting unit for the goodwill impairment tests, we used a weighted average of the discounted cash flow method and a market-based method (comparing the Company’s equity and analyzing multiples of revenue for comparable companies). For the Oblong Industries reporting unit, the fair value of the reporting unit exceeded its carrying amount, therefore no impairment charge was required for the three or nine months ended September 30, 2020. For the Glowpoint reporting unit, we recorded an impairment charge on goodwill of $541,000 at March 31, 2020 as the carrying amount of the reporting unit exceeded its fair value on the test date. This charge is recognized as “Impairment Charges” on our condensed consolidated Statements of Operations. The Glowpoint reporting unit’s impairment charges for the nine months ended September 30, 2019 were $453,000. The activity in goodwill during the nine months ended September 30, 2020 and the year ended December 31, 2019 is shown in the following table ($ in thousands): Goodwill Glowpoint Oblong Industries Total Balance December 31, 2018 $ 2,795 $ — $ 2,795 Impairment charges (2,254) — (2,254) Acquisition — 7,366 7,366 Balance December 31, 2019 541 7,366 7,907 Impairment charges (541) — (541) Balance September 30, 2020 $ — $ 7,366 $ 7,366 In the event we experience future declines in our revenue, cash flows and/or stock price, this may give rise to a triggering event that may require the Company to record additional impairment charges on goodwill in the future.

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 6 - Intangible Assets The following table presents the components of net intangible assets (in thousands): As of September 30, 2020 As of December 31, 2019 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Glowpoint Customer Relationships $ 4,335 $ (4,335) $ — $ 4,335 $ (4,335) $ — Affiliate network 994 (718) 276 994 (666) 328 Trademarks 548 (548) — 548 (504) 44 Subtotal $ 5,877 $ (5,601) $ 276 $ 5,877 $ (5,505) $ 372 Oblong Industries Developed technology 10,060 (2,016) 8,044 10,060 (504) 9,556 Trade names 2,410 (241) 2,169 2,410 (60) 2,350 Distributor relationships 310 (62) 248 310 (16) 294 Subtotal $ 12,780 $ (2,319) $ 10,461 $ 12,780 $ (580) $ 12,200 Total $ 18,657 $ (7,920) $ 10,737 $ 18,657 $ (6,085) $ 12,572 At each reporting period, we determine if there was a triggering event that may result in an impairment of our intangible assets. During the three months ended March 31, 2020, we considered the novel Coronavirus (COVID-19) pandemic and resulting declines in certain of the Company’s revenue to be a triggering event for an interim impairment test of intangible assets for both reporting units. During the three months ended September 30, 2020, we did not identify any triggering events, therefore no impairment charges were required for the three and nine months ended September 30, 2020. Intangible assets with finite lives are amortized using the straight-line method over the estimated economic lives of the assets, which range from five years to twelve years in accordance with ASC Topic 350. The weighted average lives for the components of intangible assets are as follows: Glowpoint Affiliate network 12 years Trademarks 8 years Oblong Industries Developed technology 5 years Trade names 10 years Distributor relationships 5 years Related amortization expense was $611,000 and $1,835,000 for the three and nine months ended September 30, 2020, respectively. Related amortization expense was $32,000 and $95,000 for the three and nine months ended September 30, 2019, respectively. The increase is the result of the October 1, 2019 Acquisition of Oblong Industries. Amortization expense for each of the next five succeeding years will be as follows (in thousands): Remainder of 2020 $ 597 2021 2,388 2022 2,386 2023 2,378 2024 1,844 Thereafter 1,144 Total $ 10,737

Accrued Expenses and Other Liab

Accrued Expenses and Other Liabilities	9 Months Ended
	Sep. 30, 2020
Other Liabilities Disclosure [Abstract]
Accrued Expenses and Other Liabilities	Note 7 - Accrued Expenses and Other Liabilities Accrued expenses and other liabilities consisted of the following (in thousands): September 30, December 31, 2020 2019 Accrued compensation costs $ 627 $ 810 Other accrued expenses and liabilities 858 843 Accrued dividends on Series A-2 Preferred Stock 4 99 Accrued expenses and other liabilities $ 1,489 $ 1,752

Debt

Debt	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Debt	Note 8 - Debt Debt consisted of the following (in thousands): September 30, December 31, 2020 2019 SVB Loan Principal $ 5,609 $ 5,609 PPP Loan Principal 2,417 — Total Loan Principal 8,026 5,609 Less: Unamortized SVB debt discount (49) (102) Net carrying value 7,977 5,507 Less: SVB current maturities, net of debt discount 3,465 2,664 Less: PPP current maturities 1,477 — Total current maturities, net of debt discount 4,942 2,664 Long-term SVB obligations, net of current maturities and debt discount 2,095 2,843 Long-term PPP obligations, net of current maturities 940 — Total long-term obligations, net of current maturities and debt discount $ 3,035 $ 2,843 Future minimum principal payments are as follows (in thousands): Future Minimum Principal Payments SVB Loan PPP Loan Total Remainder of 2020 $ 874 $ 269 $ 1,143 2021 3,498 1,611 5,109 2022 1,237 537 1,774 $ 5,609 $ 2,417 $ 8,026 Silicon Valley Bank Loan Agreement and Warrant Subsequent to the period of this report, the Company and SVB completed an agreement to satisfy all outstanding obligations under the SVB Loan Agreement. As a result, as of the filing date of this Report, the Company has no outstanding obligations under the SVB Loan Agreement. For further discussion, see Note 14 - Subsequent Events. On October 1, 2019, in connection with the Acquisition of Oblong Industries, the Company and Oblong Industries, as borrowers, and SVB, as lender, executed an amendment to the SVB Loan Agreement. On October 24, 2019, GP Communications joined the SVB Loan Agreement as an additional co-borrower. The SVB Loan Agreement provided for a term loan facility of approximately $5,247,000, (the “SVB Loan”), all of which was outstanding at December 31, 2019 and September 30, 2020. On June 26, 2020, the Company and SVB entered into a Default Waiver and First Amendment (the“Amendment”) to the SVB Loan Agreement. Under the Amendment, the Bank agreed to extend the interest-only payment period under the SVB Loan Agreement through September 30, 2020, after which equal monthly principal payments of $291,500 were payable over an eighteen month period from October 1, 2020 through March 1, 2022 (the “Maturity Date”) to fully repay the loan. The SVB Loan originally accrued interest at a rate equal to the Prime Rate (as defined in the SVB Loan Agreement) plus 200 basis points (for a total of 6.75% as of December 31, 2019). In connection with the Amendment, the interest rate under the Loan was increased to the Prime Rate plus 425 basis points (for a total of 7.50% as of September 30, 2020). In connection with its execution of the amended SVB Loan Agreement on October 1, 2019, the Company i) agreed to pay SVB a fee of $100,000 on April 1, 2020 (the “Deferral Fee”) and ii) issued a warrant to SVB that entitles SVB to purchase 72,394 shares of the Company’s Common Stock at an exercise price of $0.01 per share (the “SVB Warrant”). Pursuant to the Amendment, the due date for the Deferral Fee was changed to the earlier of (i) the maturity of the loan, (ii) the repayment in full of all principal and interest owing under the Loan Agreement, and (iii) occurrence of an event of default under the Loan Agreement. The SVB Warrant has a ten (10) year term. The fair value of the SVB Warrant was recorded to additional paid-in capital and was determined to be $72,000 using the Black-Scholes model. The total obligations under the SVB Loan Agreement were $5,609,000, comprised of $5,247,000 for the SVB Loan, the Deferral Fee and the Maturity Fee of $262,000 that was assumed on October 1, 2019 as part of the Acquisition. The Deferral Fee, the fair value of the SVB Warrant, and $20,000 of debt issuance costs totaled $192,000 and was recorded as a discount to the debt. This debt discount is being amortized to interest expense using the effective interest method over the term of the debt. During the three and nine months ended September 30, 2020, the Company amortized $8,000 and $53,000 of the debt discount, respectively, which is recorded in “Interest and other expense, Net” on our condensed consolidated Statements of Operations. The remaining unamortized debt discount as of September 30, 2020 and December 31, 2019 was $49,000 and $102,000, respectively. The obligations under the SVB Loan Agreement were secured by substantially all of the assets of Oblong and its subsidiaries. The SVB Loan Agreement contained certain restrictions and covenants, which, among other things, subject to certain exceptions, restricted the Company’s ability to dispose of any portion of its business or property, engage in certain material changes to its business, enter into a merger, incur additional debt or make guarantees, pay dividends or make distribution payments on, or redeem, retire, or repurchase any capital stock (subject to certain exceptions), create liens or other encumbrances, or enter into related party transactions outside of the ordinary course of business. The SVB Loan Agreement also contained customary events of default, including failure to pay any principal or interest when due, failure to perform or observe covenants, breaches of representations and warranties, certain cross defaults, certain bankruptcy related events, monetary judgments defaults and the Company’s de-listing from the NYSE American without a listing of its Common Stock on another nationally recognized stock exchange. Upon the occurrence of an event of default, the outstanding obligations under the SVB Loan Agreement could be accelerated and become immediately due and payable. Paycheck Protection Program Loan On April 10, 2020 (the “Origination Date”), the Company received $2,417,000 in aggregate loan proceeds (the “PPP Loan”) from MidFirst Bank (the “Lender”) pursuant to the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The PPP Loan is evidenced by a Promissory Note (the “Note”), dated April 10, 2020, by and between the Company and the Lender. Subject to the terms of the Note, the PPP Loan bears interest at a fixed rate of one percent (1.0%) per annum. Payments of principal and interest are deferred for the first six months following the Origination Date. Following the deferral period, the Company will be required to make payments of principal plus interest accrued under the PPP Loan to the Lender in 18 monthly installments based upon an amortization schedule to be determined by the Lender based on the principal balance of the Note outstanding following the deferral period and taking into consideration any portion of the PPP Loan that is forgiven prior to that time. The PPP Loan is unsecured and guaranteed by the U.S. Small Business Administration. The Company may apply to the Lender for forgiveness of some or all of the Note with the amount which may be forgiven equal to the sum of eligible payroll costs, mortgage interest, covered rent, and covered utility payments, in each case incurred by the Company during the twenty-four week period following the Origination Date, calculated in accordance with the terms of the CARES Act. Certain reductions in Company payroll costs during this period may reduce the amount of the Note eligible for forgiveness. There is no guarantee that the Company will receive forgiveness for any fixed amount of any PPP Loan principal received by the Company. The Note provides for customary events of default including, among other things, failure to make any payment when due, cross-defaults under any loan documents with the Lender, certain cross-defaults under agreements with third parties, inaccuracy of representations and warranties, events of dissolution or insolvency, certain change of control events, and material adverse changes in the Company’s financial condition. If an event of default occurs, the Lender will have the right to accelerate indebtedness under the PPP Loan and/or pursue other remedies available to the Lender at law or in equity.

Preferred Stock

Preferred Stock	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Preferred Stock	Note 9 - Preferred Stock Our Certificate of Incorporation authorizes the issuance of up to 5,000,000 shares of preferred stock. As of September 30, 2020, there were: (i) 100 shares of Perpetual Series B-1 Preferred Stock authorized and no shares issued or outstanding; (ii) 7,500 shares of Series A-2 Convertible Preferred Stock authorized and 45 shares issued and outstanding (the “Series A-2 Preferred Stock”); (iii) 2,800 shares of 0% Series B Convertible Preferred Stock (“Series B Preferred Stock”) authorized and no shares issued and outstanding; (iv) 1,750 shares of 0% Series C Convertible Preferred Stock (“Series C Preferred Stock”) authorized and 250 shares issued and outstanding; (v) 4,000 shares of Series D Convertible Preferred Stock authorized and no shares issued or outstanding; (vi) 100 shares of Perpetual Series B Preferred Stock authorized and no shares issued or outstanding; (vii) 1,750,000 shares of 6.0% Series D Convertible Preferred Stock (“Series D Preferred Stock”) authorized and 1,702,010 shares issued and outstanding; and (viii) 175,000 shares of 6.0% Series E Convertible Preferred Stock (“Series E Preferred Stock”) authorized and 131,579 shares issued and outstanding. Series A-2 Preferred Stock Each share of Series A-2 Preferred Stock has a stated value of $7,500 per share (the “A-2 Stated Value”), a liquidation preference equal to the Series A-2 Stated Value, and is convertible at the holder’s election into common stock at a conversion price per share of $21.60 as of September 30, 2020. Therefore, each share of Series A-2 Preferred Stock is convertible into 345 shares of common stock, for an aggregate of 15,625 shares of common stock as of September 30, 2020. The conversion price is subject to adjustment upon the occurrence of certain events set forth in our Certificate of Incorporation. Subsequent to the period of this Report, the Company entered into a securities purchase agreement for the issuance of 1,043,000 shares of the Company’s Common Stock at the price of $2.85 per share. Due to this issuance, and in accordance with the provisions of the Series A-2 Preferred Stock, the conversion price of the Series A-2 Preferred Stock was reduced to $18.49 per share. This new conversion price results in each share of Series A-2 Preferred Stock being convertible into 405 shares of common stock, for an aggregate of 18,131 shares. The Series A-2 Preferred Stock is senior to all outstanding classes of the Company’s equity, has weighted average anti-dilution protection and, effective January 1, 2013, entitled to cumulative dividends at a rate of 5.0% per annum, payable quarterly, based on the Series A-2 Stated Value and payable at the option of the holder in cash or through the issuance of a number of additional shares of Series A-2 Preferred Stock with an aggregate liquidation preference equal to the dividend amount payable on the applicable dividend payment date. As of September 30, 2020 and December 31, 2019, the Company has recorded $4,000 and $99,000, respectively, in accrued dividends on the accompanying condensed consolidated Balance Sheets related to the Series A-2 Preferred Stock outstanding. During the nine months ended September 30, 2020, $99,000 of accrued dividends as of December 31, 2019, were exchanged for 13 shares of Series A-2 Preferred Stock. The Company, at its option, may redeem all or a portion of the Series A-2 Preferred Stock in cash at a price per share of $8,250 (equal to $7,500 per share multiplied by 110%) plus all accrued and unpaid dividends. In accordance with ASC Topic 815, we evaluated whether our convertible preferred stock contains provisions that protect holders from declines in our stock price or otherwise could result in modification of the exercise price and/or shares to be issued under the respective preferred stock agreements based on a variable that is not an input to the fair value of a “fixed-for-fixed” option and require a derivative liability. The Company determined no derivative liability is required under ASC Topic 815 with respect to our convertible preferred stock. A contingent beneficial conversion amount is required to be calculated and recognized when and if the adjusted $21.60 conversion price of the Series A-2 Preferred Stock is adjusted to reflect a down round stock issuance that reduces the conversion price below the $11.16 fair value of the common stock on the issuance date of the Series A-2 Preferred Stock. Series C Preferred Stock On January 25, 2018, the Company closed a registered direct offering of 1,750 shares of its Series C Preferred Stock for total gross proceeds to the Company of $1,750,000. The shares of Series C Preferred Stock were sold at a price equal to their stated value of $1,000 per share and are convertible into shares of the Company’s common stock at a conversion price of $3.00 per share. During the nine months ended September 30, 2020 and 2019, 225 and 50 shares of Series C Preferred Stock were converted to 75,000 and 16,667 shares of the Company’s common stock, respectively. As of September 30, 2020, 250 shares of Series C Preferred Stock remained issued and outstanding. The Company has agreed that it will not enter into certain “fundamental transactions,” including transactions constituting a change of control of the Company, certain reorganization transactions or a sale of all or substantially all of the Company’s assets, except as pursuant to written agreements in form and substance satisfactory to the holders of a majority of the outstanding shares of Series C Preferred Stock including the Lead Investor and on terms with respect to the Series C Preferred Stock as set forth in the Certificate of Designation of Rights, Powers, Preferences, Privileges and Restrictions of the Series C Preferred Stock. Series D Preferred Stock In connection with the Acquisition (see Note 3 - Oblong Industries Acquisition), the Company issued an aggregate of 1,686,659 shares of Series D Preferred Stock and an aggregate of 49,967 restricted shares of Series D Preferred Stock (“Restricted Series D Preferred Stock”), the latter of which are subject to vesting over a two-year period following the Closing Date of the Acquisition. Each share of Series D Preferred Stock is automatically convertible into a number of shares of the Company’s common stock equal to the accrued value of the share (initially $28.50), plus any accrued dividends thereon, divided by the Conversion Price (initially $2.85 per share, subject to specified adjustments) upon the completion of both (i) approval of such conversion by the Company’s stockholders (which occurred on December 19, 2019); and (ii) the receipt of all required authorizations and approval of a new listing application for the combined organization from the NYSE American. Pursuant to the terms of the Series D Certificate of Designations, each share of Series D Preferred Stock is entitled to receive an annual dividend equal to 6.0% of its then-existing Accrued Value per annum, commencing on the first anniversary of the issuance of the Series D Preferred Stock (or October 1, 2020). Prior to the first anniversary of the issuance of the Series D Preferred Stock no dividends will accrue on such stock. Dividends are cumulative and accrue daily in arrears. If the Company’s Board of Directors does not declare any applicable dividend payment in cash, the Accrued Value of the Series D Preferred Stock will be increased by the amount of such dividend payment. As of September 30, 2020, no dividends have been accrued. Series E Preferred Stock On October 1, 2019, Oblong entered into a Series E Preferred Stock Purchase Agreement (the “Purchase Agreement”) with the investors party thereto, who, prior to the closing of the Acquisition, were stockholders of Oblong Industries (the “Purchasers”), relating to the offer and sale by the Company in a private placement (the “Offering”) of up to 131,579 shares of its Series E Preferred Stock at a price of $28.50 per share. At an initial closing on October 1, 2019 and a subsequent closing on December 18, 2019, the Company sold a total of 131,579 shares of Series E Preferred Stock for net proceeds of approximately $3,750,000. The 131,579 shares of Series E Preferred Stock issued by the Company in the Series E Financing have an aggregate Accrued Value of $3,750,000 and upon their conversion will convert at a conversion price of $2.85 per share into 1,315,790 common shares. Like the Series D Preferred Stock, each share of Series E Preferred Stock is automatically convertible into common stock upon the receipt of all required authorizations and approval of a new listing application for the combined organization from the NYSE American. Pursuant to the terms of the Series E Certificate of Designations, each share of Series E Preferred Stock is entitled to receive an annual dividend equal to 6.0% of its then-existing Accrued Value per annum, commencing on the first anniversary of the issuance of the Series E Preferred Stock (or October 1, 2019 or December 18, 2019, as applicable). Prior to the first anniversary of the issuance of the Series E Preferred Stock no dividends will accrue on such stock. Dividends are cumulative and accrue daily in arrears. If the Company’s Board of Directors does not declare any applicable dividend payment in cash, the Accrued Value of the Series E Preferred Stock will be increased by the amount of such dividend payment. As of September 30, 2020, no dividends have been accrued. In connection with the Purchase Agreement, the Company executed a Registration Rights Agreement, dated October 1, 2019 (the “Rights Agreement”). Pursuant to the Rights Agreement, among other things, the Company has provided the Purchasers with certain rights to require it to file and maintain the effectiveness of a registration statement with respect to the re-sale of shares of Common Stock underlying the shares of Series D Preferred Stock issued in the Oblong Transaction and Series E Preferred Stock sold in the Series E Financing. If the Series D and Series E Preferred Stock had been converted to common stock as of September 30, 2020, 17,020,100 and 1,315,790 shares of common stock would have been issued for the Series D and Series E Preferred Stock, respectively, which would have increased our outstanding shares of common stock from 5,242,558 to 23,578,448. Both the Series D and Series E Preferred Stock remain outstanding as of September 30, 2020 and as of the filing of this Report. The Company intends to file a new listing application with the NYSE American as soon as possible upon satisfying the initial listing standards. Among other requirements, these standards require the Company to have at least $15 million of non-affiliate public float, which, under the Company’s current financial situation, may be difficult or impossible for the Company to satisfy.

Stock Based Compensation

Stock Based Compensation	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Stock Based Compensation	Note 10 - Stock Based Compensation 2019 Equity Incentive Plan On December 19, 2019, the Oblong, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders. The 2019 Plan is an omnibus equity incentive plan pursuant to which the Company may grant equity and cash incentive awards to certain key service providers of the Company and its subsidiaries. The 2019 Plan replaces the Glowpoint, Inc. 2014 Equity Incentive Plan (the “Prior Plan”), which was adopted by the Company’s Board of Directors on April 22, 2014, and subsequently approved by the Company’s stockholders. Following approval of the 2019 Plan, the Company terminated the Prior Plan and may no longer make grants under the Prior Plan; however, any outstanding equity awards granted under the Prior Plan will continue to be governed by the terms of the Prior Plan. As of September 30, 2020, no restricted stock units were outstanding under the Prior Plan. As of September 30, 2020, the share pool available for new grants under the 2019 Plan is 3,021,000, which is equal to the sum of (i) 2,600,000 shares of the Company’s Common Stock and (ii) the 421,000 shares of the Company’s Common Stock that remained available for issuance under the Prior Plan. No equity awards were granted under the 2019 Plan during the nine months ended September 30, 2020. 2007 Stock Incentive Plan In May 2014, the Board terminated the Company’s 2007 Stock Incentive Plan (the “2007 Plan”). Notwithstanding the termination of the 2007 Plan, outstanding awards under the 2007 Plan will remain in effect in accordance with their terms. As of September 30, 2020, options to purchase a total of 107,500 shares of common stock and 627 shares of restricted stock were outstanding under the 2007 Plan. No shares are available for issuance under the 2007 Plan. Stock Options For the nine months ended September 30, 2020 and the year ended December 31, 2019, other than the options granted to certain former holders of options to purchase shares of Oblong Industries’ common stock, for which no stock-based compensation was recorded as discussed below, no stock options were granted. A summary of stock options expired and forfeited under our plans and options outstanding as of, and changes made during, the nine months ended September 30, 2020 and the year ended December 31, 2019 is presented below: Outstanding and Exerciseable Number of Options Weighted Average Exercise Price Options outstanding, December 31, 2018 118,003 $ 19.90 Exchanged for Oblong Industries stock options 107,845 4.92 Expired (440) 16.48 Forfeited (10,063) 23.20 Options outstanding, December 31, 2019 215,345 12.27 Expired (107,845) 4.92 Options outstanding and exercisable, September 30, 2020 107,500 $ 19.64 Additional information as of September 30, 2020 is as follows: Outstanding and Exercisable Range of price Number Weighted Weighted $0.00 – $10.00 2,500 2.70 $ 9.00 $10.01 – $20.00 97,500 2.31 19.32 $20.01 – $30.00 2,500 1.68 21.80 $30.01 – $40.00 5,000 1.45 30.20 107,500 2.26 $ 19.64 In connection with the Acquisition, all options to purchase shares of Oblong Industries’ common stock held by previously terminated employees of Oblong Industries were assumed by the Company and deemed, in the aggregate, to constitute options to acquire a total of 107,845 shares of the Company’s common stock, at a volume weighted average exercise price of $4.92 per share and a remaining exercise period of one year. These options all expired on September 30, 2020. No stock-based compensation expense was recorded in the three and nine months ended September 30, 2020 for these stock options as the value for these options was recorded as part of the consideration of the Acquisition given that these options were issued to terminated employees. The intrinsic value of vested options, unvested options and exercised options were not significant for all periods presented. There was no remaining unrecognized stock-based compensation expense for options at September 30, 2020 as all options were vested. Restricted Stock Awards A summary of restricted stock granted, vested and unvested outstanding as of, and changes made during, the nine months ended September 30, 2020 and the year ended December 31, 2019, is presented below: Restricted Shares Weighted Average Grant Date Price Unvested restricted stock outstanding, December 31, 2018 11,320 $ 14.88 Granted — — Vested (1,372) 15.72 Forfeited (9,321) 14.70 Unvested restricted stock outstanding, December 31, 2019 627 15.80 Unvested restricted stock outstanding, September 30, 2020 627 $ 15.80 Stock-based compensation expense relating to restricted stock awards is allocated as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 General and administrative — — — 3 $ — $ — $ — $ 3 The unvested restricted stock award as of September 30, 2020 was issued in 2014 and vests over the lesser of ten years, a change in control, or separation from the company. Due to the variability of the vesting, the expense was amortized over an average service period of five years; therefore, there is no unrecognized stock-based compensation expense for restricted stock awards for the period ended September 30, 2020. Restricted Stock Units A summary of restricted stock units (“RSUs”) granted, vested, forfeited and unvested outstanding as of, and changes made during, the nine months ended September 30, 2020 and the year ended December 31, 2019, is presented below: Restricted Stock Units Weighted Average Grant Price Unvested restricted stock units outstanding, December 31, 2018 503,518 $ 1.94 Granted 55,479 1.30 Vested (114,505) 3.05 Forfeited (421,158) 1.54 Unvested restricted stock units outstanding, December 31, 2019 23,334 2.20 Vested (23,334) 2.20 Unvested restricted stock units outstanding, September 30, 2020 — $ — As of September 30, 2020, 28,904 vested RSU’s remain outstanding as shares of common stock have not yet been delivered for these units in accordance with the terms of the RSU’s. Stock-based compensation expense relating to restricted stock units is allocated as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Cost of revenue $ — $ 2 $ — $ 10 Research and development — 2 — 11 Sales and marketing — — — — General and administrative — 10 6 43 $ — $ 14 $ 6 $ 64 There was no remaining unrecognized stock-based compensation expense for restricted stock units at September 30, 2020. There was no tax benefit recognized for stock-based compensation expense for the nine months ended September 30, 2020 or the year ended December 31, 2019. No compensation costs were capitalized as part of the cost of an asset during the periods presented. Restricted Series D Preferred Stock In connection with the Acquisition, all options to purchase shares of Oblong Industries’ common stock held by existing employees of Oblong Industries were canceled and exchanged for an aggregate of 49,967 shares of Restricted Series D Preferred Stock, which are subject to vesting over a two-year period following the Closing Date. Stock-based compensation expense relating to Restricted Series D Preferred Stock is allocated as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, Three and Nine Months Ended September 30, 2020 2020 2019 Research and development $ 11 $ 39 $ — Sales and marketing 7 17 — General and administrative 10 27 — $ 28 $ 83 $ — During the three and nine months ended September 30, 2020, 1,086 and 32,891 shares of Restricted Series D Preferred Stock were forfeited, respectively. As of September 30, 2020, 5,123 shares of Restricted Series D Preferred Stock remain outstanding. The remaining unrecognized stock-based compensation expense for Restricted Series D Preferred Stock at September 30, 2020 was $57,000, and will be recognized over a weighted average period of 1 year.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Net Loss Per Share	Note 11 - Net Loss Per Share Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at September 30, 2020 and 2019, is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant. Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, RSUs, and unvested restricted stock, to the extent they are dilutive. For the three and nine months ended September 30, 2020 and 2019, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss). The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Numerator: Net loss $ (2,085) $ (640) $ (8,598) $ (2,113) Less: preferred stock dividends (4) (4) (12) (23) Net loss attributable to common stockholders $ (2,089) $ (644) $ (8,610) $ (2,136) Denominator: Weighted-average number of shares of common stock for diluted net loss per share 5,257 5,184 5,237 5,128 Basic and diluted net loss per share $ (0.40) $ (0.12) $ (1.64) $ (0.42) The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss): Nine Months Ended September 30, 2020 2019 Unvested restricted stock units — 23,334 Outstanding stock options 107,500 107,500 Unvested restricted stock awards 627 627 Shares of common stock issuable upon conversion of Series A-2 preferred stock 15,545 10,978 Shares of common stock issuable upon conversion of Series C preferred stock 83,333 158,333 Shares of common stock issuable upon conversion of Series D preferred stock 17,020,100 — Shares of common stock issuable upon conversion of Series E preferred stock 1,315,790 — Warrants 72,394 —

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Segment Reporting	Note 12 - Segment Reporting Prior to the Acquisition of Oblong Industries on October 1, 2019, the Company operated in one segment. Following October 1, 2019, the former businesses of Glowpoint and Oblong Industries were managed separately and involve different products and services. Accordingly, the Company currently operates in two segments: (1) the Glowpoint (now named Oblong) business, which mainly consists of managed services for video collaboration and network applications; and (2) the Oblong Industries business, which consists of products and services for visual collaboration technologies. Because the closing of the Acquisition of Oblong Industries occurred on October 1, 2019, the Company’s condensed consolidated financial statements as of and for the three and nine months ended September 30, 2020 and 2019 included in this Report only reflect Oblong Industries’ financial results for the first through third quarters of 2020. Certain information concerning the Company’s segments for the three and nine months ended September 30, 2020 is presented in the following tables (in thousands): Three Months ended September 30, 2020 Glowpoint Oblong Industries Total Revenue $ 1,324 $ 1,942 $ 3,266 Cost of revenues 893 719 1,612 Gross profit $ 431 $ 1,223 $ 1,654 Gross profit % 33 % 63 % 51 % Allocated operating expenses $ 1,187 $ 1,477 $ 2,664 Unallocated operating expenses 980 Total operating expenses $ 1,187 $ 1,477 $ 3,644 Loss from operations $ (756) $ (254) $ (1,990) Interest and other expense, net 5 90 95 Net loss $ (761) $ (344) $ (2,085) Nine Months Ended September 30, Glowpoint Oblong Industries Total Revenue $ 4,741 $ 6,669 $ 11,410 Cost of revenues 2,948 2,736 5,684 Gross profit $ 1,793 $ 3,933 $ 5,726 Gross profit % 38 % 59 % 50 % Allocated operating expenses $ 3,398 $ 7,545 $ 10,943 Unallocated operating expenses 3,059 Total operating expenses $ 3,398 $ 7,545 $ 14,002 Loss from operations $ (1,605) $ (3,612) $ (8,276) Interest and other expense, net 12 310 322 Net loss $ (1,617) $ (3,922) $ (8,598) Unallocated operating expenses include costs for the three and nine months ended September 30, 2020 that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses. Interest and other expense, net, is also not allocated to the operating segments. For the three and nine months ended September 30, 2020 and 2019, there was no material revenue attributable to any individual foreign country. Approximately 1% of foreign revenue is billed in foreign currency and foreign currency gains and losses are not material. Revenue by geographic area is allocated as follows (in thousands): Three Months ended September 30, 2020 2019 Domestic $ 2,080 $ 1,571 Foreign 1,186 799 $ 3,266 $ 2,370 Nine Months Ended September 30, 2020 2019 Domestic $ 7,536 $ 5,042 Foreign 3,874 2,361 $ 11,410 $ 7,403 Disaggregated information for the Company’s revenue has been recognized in the accompanying condensed consolidated statements of operations and is presented below according to contract type (in thousands): Three Months ended September 30, 2020 % of Revenue 2019 % of Revenue Revenue: Glowpoint Video collaboration services $ 249 8 % $ 1,317 56 % Network services 1,028 31 % 969 41 % Professional and other services 47 1 % 84 4 % Total Glowpoint revenue $ 1,324 40 % $ 2,370 100 % Revenue: Oblong Industries Visual collaboration product offerings $ 1,686 52 % — — % Professional services — — % — — % Licensing 256 8 % — — % Total Oblong Industries revenue $ 1,942 60 % — — % Total revenue $ 3,266 100 % $ 2,370 100 % Nine Months Ended September 30, 2020 % of Revenue 2019 % of Revenue Revenue: Glowpoint Video collaboration services $ 1,847 16 % $ 4,335 59 % Network services 2,719 24 % 2,879 39 % Professional and other services 175 2 % 189 3 % Total Glowpoint revenue 4,741 42 % 7,403 100 % Revenue: Oblong Industries Visual collaboration product offerings 4,931 43 % — — % Professional services 898 8 % — — % Licensing 840 7 % — — % Total Oblong Industries revenue 6,669 58 % — — % Total revenue $ 11,410 100 % $ 7,403 100.00 % Glowpoint’s fixed assets were 100% located in domestic markets as of September 30, 2020 and December 31, 2019. Oblong Industries’ long-lived assets were located 88% in domestic and 12% in foreign markets as of September 30, 2020. The disaggregation of the Company’s total assets as of September 30, 2020 is presented below (in thousands): As of September 30, 2020 Glowpoint Oblong Total Total assets $ 3,370 $ 23,872 $ 27,242 The Company considers a significant customer to be one that comprises more than 10% of the Company’s consolidated revenues or accounts receivable. The loss of or a reduction in sales or anticipated sales to our most significant or several of our smaller customers could have a material adverse effect on our business, financial condition and results of operations. Concentration of revenues was as follows: Three Months Ended September 30, 2020 2019 Segment % of Revenue % of Revenue Customer A Glowpoint 20 % 26 % Customer B Oblong Industries 12 % — % Customer C Glowpoint * 25 % * The amount did not exceed 10% of the Company’s consolidated total revenues. Nine Months Ended September 30, 2020 2019 Segment % of Revenue % of Revenue Customer A Glowpoint 17 % 23 % Customer B Oblong Industries 19 % — % Customer C Glowpoint * 27 % * The amount did not exceed 10% of the Company’s consolidated total revenues. Concentration of accounts receivable was as follows: As of September 30, 2020 2020 2019 Segment % of Accounts Receivable % of Accounts Receivable Customer A Glowpoint 20 % 15 % Customer B Oblong Industries * — % Customer C Glowpoint * 51 % Customer E Oblong Industries 15 % — % * The amount did not exceed 10% of the Company’s consolidated total accounts receivable.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 13 - Commitments and Contingencies Operating Leases We lease office and warehouse space in Los Angeles, California; Boston, Massachusetts; Dallas, Texas; Los Altos, California; Herndon, Virginia; and Munich, Germany. These leases expire between October 2020 and 2023. Lease expense for the three and nine months ended September 30, 2020 and 2019 were $267,000, $915,000, $52,000, and $153,000, respectively. The year over year increases are the result of acquiring lease obligations as part of the October 1, 2019 Acquisition of Oblong Industries. The Company primarily leases facilities for office and data center space under non-cancellable operating leases for its U.S. and international locations that expire at various dates through 2023. For leases with a term greater than 12 months, the Company recognizes a right-of-use asset and a lease liability based on the present value of lease payments over the lease term. Variable lease payments are not included in the lease payments to measure the lease liability and are expensed as incurred. The Company’s leases have remaining terms of one As the Company's leases do not provide a readily determinable implicit rate, the Company uses the incremental borrowing rate at lease commencement, which was determined using a portfolio approach, based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. The Company uses the implicit rate when a rate is readily determinable. Operating lease expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recognized on the balance sheet and the expense for these short-term leases is recognized on a straight-line basis over the lease term. Common area maintenance fees (or CAMs) and other charges related to these leases continue to be expensed as incurred. The following provides balance sheet information related to leases as of September 30, 2020 (in thousands): September 30, 2020 Assets Operating lease, right-of-use asset, net $ 1,665 Liabilities Current portion of operating lease liabilities $ 907 Operating lease liabilities, net of current portion 889 Total operating lease liabilities $ 1,796 The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands): Remaining Lease Payments Remainder of 2020 $ 258 2021 968 2022 566 2023 116 Total lease payments $ 1,908 Effect of discounting (112) Total lease liability $ 1,796 On January 1, 2019, the Company recognized ROU assets and lease liabilities of approximately $99,000 and $111,000, respectively, using an estimated incremental borrowing rate of 7.75%. On October 1, 2019 (the closing date of the Acquisition of Oblong Industries), the Company recognized ROU assets and lease liabilities for Oblong Industries of approximately $3,376,000 and $3,578,000, respectively, using an estimated incremental borrowing rate of 6%. The ROU assets and lease liabilities are recorded on the Company’s condensed consolidated balance sheets as of September 30, 2020 and December 31, 2019. During the nine months ended September 30, 2020, non-cash immaterial out-of-period adjustments of approximately $195,000 were recorded to reduce the right of use asset and lease liability. These adjustments related to an error in the calculation of these amounts, in connection with the Oblong Acquisition. During the nine months ended September 30, 2020, the Company entered into one new lease, in Los Angeles, for warehouse space. The new lease commences on September 1, 2020 and has a term of 18 months. The new lease resulted in an addition to ROU Assets, and corresponding increase to lease liability, of $116,000. During the nine months ended September 30, 2020, the Company exited four of its leases, one in New York, one in London, one in Atlanta, and one in Los Angeles. The New York and London leases were exited in April 2020 when the Company elected not to renew the leases. The Atlanta and Los Angeles leases were exited in July 2020 and August 2020, respectively, when the Company negotiated terminations of the leases. These lease exits resulted in the reduction of ROU assets and the reduction of lease Liability. The New York ROU Asset was fully amortized, and the lease liability had been fully paid, as of the date of exit resulting in a net effect of zero on the ROU asset and operating lease liability on the Company’s unaudited Condensed, Consolidated Balance Sheet durng the first quarter of 2020. The Company had originally planned to renew the London Lease, and, pursuant to ASC 842, had recorded additional operating lease liability and ROU Asset value. Upon the exit of the London Lease, the Company recorded a disposal of ROU Asset value, and corresponding reduction of operating lease liability, of $214,000 on the Company’s unaudited Condensed, Consolidated Balance Sheet during the first quarter of 2020. On April 24, 2020, the Company signed an amendment to the lease on our Los Angeles warehouse in order to exit the lease early. The original termination date of the lease was the end of May 2022 and we exited the lease at the end of August 2020. This transaction resulted in the disposal of $317,000 in ROU assets and a reduction of $333,000 of lease liability during the second quarter of 2020. On July 31, 2020, the Company entered into a termination agreement related to our lease in Atlanta. The original termination date of the lease was the end of October 2020 and the termination agreement allows for the termination of the lease on July 31, 2020, in exchange for a cancellation fee of $10,000. Upon exit of the Atlanta lease, the Company recorded a disposal of ROU Asset value of $18,000, and a reduction of lease liability of $21,000, during the three months ended September 30, 2020. Claim Related to Series A-2 Preferred Stock As discussed in Note 3 - Oblong Industries Acquisition, on October 1, 2019, the Company closed its Acquisition of Oblong Industries, in connection with which it became a co-borrower under the SVB Loan Agreement. Following consummation of the Acquisition, the holder of the Company’s Series A-2 Preferred Stock communicated to the Company his belief that the Company’s execution of the joinder to the SVB Loan Agreement without his consent contravened approval rights in the Series A-2 Certificate of Designations. The Company has not accrued any liabilities for this matter as of September 30, 2020. As of the filing of this Report, there has been no further update regarding this matter. COVID-19 On March 11, 2020, the World Health Organization announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, the U.S. President announced a National Emergency relating to the disease. There is a possibility of continued widespread infection in the United States and abroad, with the potential for catastrophic impact. National, state and local authorities have required or recommended social distancing and imposed quarantine and isolation measures on large portions of the population, including mandatory business closures. These measures, while intended to protect human life, have had, and may continue to have, serious adverse impacts on domestic and foreign economies of uncertain severity and duration. On June 8, 2020, the National Bureau of Economic Research indicated that the U.S. economy had entered a recession. The sweeping nature of the coronavirus pandemic makes it extremely difficult to predict how the Company’s business and operations will be affected in the longer run, but we expect that it may materially affect our business, financial condition and results of operations. The extent to which the coronavirus impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others. Moreover, the coronavirus outbreak has begun to have indeterminable adverse effects on general commercial activity and the world economy, and our business and results of operations could be adversely affected to the extent that this coronavirus or any other epidemic harms the global economy generally and/or the markets in which we operate specifically. Any of the foregoing factors, or other cascading effects of the coronavirus pandemic that are not currently foreseeable, could materially increase our costs, negatively impact our revenues and damage the Company’s results of operations and its liquidity position, possibly to a significant degree. The duration of any such impacts cannot be predicted. Effective April 30, 2020, an existing major customer of the Company suspended certain professional services we provided to the them, due to cost cutting measures due to COVID-19. These services accounted for $1.0 million (9%) of the Company’s revenue for the nine months ended September 30, 2020, none of which occurred during the three months ended September 30,

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 14 - Subsequent Events Private Placement Transaction On October 21, 2020, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with accredited investors (the “Purchasers”), providing for the offer and sale by the Company to the Purchasers in a private placement of (i) 1,043,000 shares of the Company’s common stock, at a price of $2.85 per share in cash, and (ii) warrants to purchase up to 521,500 shares of common stock, for gross proceeds of $2,973,000 before deducting placement agent fees and other offering expenses (the “Private Placement”). The Private Placement closed, and the net proceeds were received, on October 22, 2020. The net proceeds of the Private Placement were used by the Company to make the Satisfaction Payment discussed under “SVB Agreement” below. SVB Agreement On October 22, 2020, the Company entered into an agreement (the “ S atisfaction Agreement”) with certain of its subsidiaries, Oblong Industries, Inc. and GP Communications, LLC (the “Guarantors”), and SVB as lender, pursuant to which SVB agreed to accept a one-time cash payment of $2,500,000 (the “Satisfaction Payment”) in satisfaction of the Company’s outstanding payment obligations under the SVB Loan Agreement, effective immediately, subject to certain terms and conditions. See Note 8 - Debt for further discussion of the SVB Loan Agreement. SVB also agreed to release the security interests and other liens previously granted to or held by SVB as security for the Company’s obligations under the SVB Loan Agreement, as well as the Guarantors’ guarantees thereof. The Company made the Satisfaction Payment on October 22, 2020.

Business Description and Sign_2

Business Description and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2019. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The December 31, 2019 year-end condensed consolidated balance sheet data in this document was derived from audited consolidated financial statements. These condensed consolidated financial statements and notes included in this quarterly report on Form 10-Q does not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2019 and notes thereto included in the Company's fiscal 2019 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on May 15, 2020 (the “2019 10-K”). The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. Because the closing of the Acquisition of Oblong Industries occurred on October 1, 2019, the Company’s condensed consolidated financial statements for the three and nine months ended September 30, 2019 included in this Report do not reflect Oblong Industries’ financial results.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of Oblong and our 100%-owned subsidiaries, (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, (ii) Oblong Industries, and (iii) the following subsidiaries of Oblong Industries: Oblong Industries Europe, S.L. and Oblong Europe Limited. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.
Segments	Segments Prior to the Acquisition of Oblong Industries on October 1, 2019, the Company operated in one segment. Following October 1, 2019, the former businesses of Glowpoint and Oblong Industries have been managed separately and involve different products and services. Accordingly, the Company currently operates in two segments: 1) the Glowpoint (now named Oblong) business, which includes managed services for video collaboration and network applications, and 2) the Oblong Industries business, which includes products and services for visual collaboration technologies. See Note 12 - Segment Reporting for further discussion.
Use of Estimates	Use of Estimates Preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability of property and equipment, and intangible assets, the inputs used in the fair value of equity based awards as well as the values ascribed to assets acquired and liabilities assumed in the business combination.
Property and Equipment	Property and EquipmentProperty and equipment are stated at cost and are depreciated over the estimated useful lives of the related assets, which range from three to ten years. Leasehold improvements are amortized over the shorter of either the asset’s useful life or the related lease term. Depreciation is computed on the straight-line method for financial reporting purposes.
Leases	LeasesThe Company determines if an arrangement is a lease at inception. For the Company’s operating leases, the right-of-use (“ROU”) assets represents the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Since all of the lease agreements do not provide an implicit rate, the Company estimated an incremental borrowing rate in determining the present value of the lease payments. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectations regarding the terms. Variable lease costs such as operating costs and property taxes are expensed as incurred.
Treasury Stock	Treasury Stock Purchases and sales of treasury stock are accounted for using the cost method. Under this method, shares acquired are recorded at the acquisition price directly to the treasury stock account. Upon sale, the treasury stock account is reduced by the original acquisition price of the shares and any difference is recorded in equity, on a first-in first-out basis. The Company does not recognize a gain or loss to income from the purchase and sale of treasury stock.
Recently Adopted Accounting Standards and Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016 the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326),” which was subsequently amended in February 2020 by ASU 2020-02 “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842).” Topic 326 introduces an impairment model that is based on expected credit losses,

Oblong Industries Acquisition (

Oblong Industries Acquisition (Tables)	9 Months Ended
	Sep. 30, 2020
Business Combinations [Abstract]
Pro Forma Information	The Company's unaudited pro forma results for the three and nine months ended September 30, 2019 are summarized in the table below, assuming the Acquisition had occurred on January 1, 2019. These unaudited pro forma results have been prepared for comparative purposes only and do not purport to be indicative of the results of operations which would have actually resulted had the Acquisition occurred on January 1, 2019, nor to be indicative of future results of operations. Pro forma and unaudited (as if the Acquisition of Oblong Industries had occurred on January 1, 2019) Three Months Ended September 30, 2019 Nine Months Ended September 30, 2019 ($ in thousands) ($ in thousands) Revenue Glowpoint $ 2,370 $ 7,403 Oblong Industries $ 4,259 $ 12,758 Pro forma total revenue $ 6,629 $ 20,161 Net loss Glowpoint $ 640 $ 2,113 Oblong Industries $ 3,756 $ 12,782 Pro forma net loss $ 4,396 $ 14,895

Goodwill (Tables)

Goodwill (Tables)	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The activity in goodwill during the nine months ended September 30, 2020 and the year ended December 31, 2019 is shown in the following table ($ in thousands): Goodwill Glowpoint Oblong Industries Total Balance December 31, 2018 $ 2,795 $ — $ 2,795 Impairment charges (2,254) — (2,254) Acquisition — 7,366 7,366 Balance December 31, 2019 541 7,366 7,907 Impairment charges (541) — (541) Balance September 30, 2020 $ — $ 7,366 $ 7,366

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following table presents the components of net intangible assets (in thousands): As of September 30, 2020 As of December 31, 2019 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Glowpoint Customer Relationships $ 4,335 $ (4,335) $ — $ 4,335 $ (4,335) $ — Affiliate network 994 (718) 276 994 (666) 328 Trademarks 548 (548) — 548 (504) 44 Subtotal $ 5,877 $ (5,601) $ 276 $ 5,877 $ (5,505) $ 372 Oblong Industries Developed technology 10,060 (2,016) 8,044 10,060 (504) 9,556 Trade names 2,410 (241) 2,169 2,410 (60) 2,350 Distributor relationships 310 (62) 248 310 (16) 294 Subtotal $ 12,780 $ (2,319) $ 10,461 $ 12,780 $ (580) $ 12,200 Total $ 18,657 $ (7,920) $ 10,737 $ 18,657 $ (6,085) $ 12,572 The weighted average lives for the components of intangible assets are as follows: Glowpoint Affiliate network 12 years Trademarks 8 years Oblong Industries Developed technology 5 years Trade names 10 years Distributor relationships 5 years
Schedule of Future Amortization Expense	Amortization expense for each of the next five succeeding years will be as follows (in thousands): Remainder of 2020 $ 597 2021 2,388 2022 2,386 2023 2,378 2024 1,844 Thereafter 1,144 Total $ 10,737

Accrued Expenses and Other Li_2

Accrued Expenses and Other Liabilities (Tables)	9 Months Ended
	Sep. 30, 2020
Other Liabilities Disclosure [Abstract]
Schedule of Accrued Expenses and Other Liabilities	Accrued expenses and other liabilities consisted of the following (in thousands): September 30, December 31, 2020 2019 Accrued compensation costs $ 627 $ 810 Other accrued expenses and liabilities 858 843 Accrued dividends on Series A-2 Preferred Stock 4 99 Accrued expenses and other liabilities $ 1,489 $ 1,752

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Schedule of Long-term Debt	Debt consisted of the following (in thousands): September 30, December 31, 2020 2019 SVB Loan Principal $ 5,609 $ 5,609 PPP Loan Principal 2,417 — Total Loan Principal 8,026 5,609 Less: Unamortized SVB debt discount (49) (102) Net carrying value 7,977 5,507 Less: SVB current maturities, net of debt discount 3,465 2,664 Less: PPP current maturities 1,477 — Total current maturities, net of debt discount 4,942 2,664 Long-term SVB obligations, net of current maturities and debt discount 2,095 2,843 Long-term PPP obligations, net of current maturities 940 — Total long-term obligations, net of current maturities and debt discount $ 3,035 $ 2,843
Schedule of Maturities of Long-term Debt	Future minimum principal payments are as follows (in thousands): Future Minimum Principal Payments SVB Loan PPP Loan Total Remainder of 2020 $ 874 $ 269 $ 1,143 2021 3,498 1,611 5,109 2022 1,237 537 1,774 $ 5,609 $ 2,417 $ 8,026

Stock Based Compensation (Table

Stock Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Compensation Expense	Stock-based compensation expense relating to Restricted Series D Preferred Stock is allocated as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, Three and Nine Months Ended September 30, 2020 2020 2019 Research and development $ 11 $ 39 $ — Sales and marketing 7 17 — General and administrative 10 27 — $ 28 $ 83 $ —
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of Options Granted, Exercised, Expired and Forfeited	A summary of stock options expired and forfeited under our plans and options outstanding as of, and changes made during, the nine months ended September 30, 2020 and the year ended December 31, 2019 is presented below: Outstanding and Exerciseable Number of Options Weighted Average Exercise Price Options outstanding, December 31, 2018 118,003 $ 19.90 Exchanged for Oblong Industries stock options 107,845 4.92 Expired (440) 16.48 Forfeited (10,063) 23.20 Options outstanding, December 31, 2019 215,345 12.27 Expired (107,845) 4.92 Options outstanding and exercisable, September 30, 2020 107,500 $ 19.64
Shares Outstanding and Exercisable, By Exercise Price Range	Additional information as of September 30, 2020 is as follows: Outstanding and Exercisable Range of price Number Weighted Weighted $0.00 – $10.00 2,500 2.70 $ 9.00 $10.01 – $20.00 97,500 2.31 19.32 $20.01 – $30.00 2,500 1.68 21.80 $30.01 – $40.00 5,000 1.45 30.20 107,500 2.26 $ 19.64
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Nonvested Share Activity	A summary of restricted stock granted, vested and unvested outstanding as of, and changes made during, the nine months ended September 30, 2020 and the year ended December 31, 2019, is presented below: Restricted Shares Weighted Average Grant Date Price Unvested restricted stock outstanding, December 31, 2018 11,320 $ 14.88 Granted — — Vested (1,372) 15.72 Forfeited (9,321) 14.70 Unvested restricted stock outstanding, December 31, 2019 627 15.80 Unvested restricted stock outstanding, September 30, 2020 627 $ 15.80
Schedule of Compensation Expense	Stock-based compensation expense relating to restricted stock awards is allocated as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 General and administrative — — — 3 $ — $ — $ — $ 3
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Nonvested Share Activity	A summary of restricted stock units (“RSUs”) granted, vested, forfeited and unvested outstanding as of, and changes made during, the nine months ended September 30, 2020 and the year ended December 31, 2019, is presented below: Restricted Stock Units Weighted Average Grant Price Unvested restricted stock units outstanding, December 31, 2018 503,518 $ 1.94 Granted 55,479 1.30 Vested (114,505) 3.05 Forfeited (421,158) 1.54 Unvested restricted stock units outstanding, December 31, 2019 23,334 2.20 Vested (23,334) 2.20 Unvested restricted stock units outstanding, September 30, 2020 — $ —
Schedule of Compensation Expense	Stock-based compensation expense relating to restricted stock units is allocated as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Cost of revenue $ — $ 2 $ — $ 10 Research and development — 2 — 11 Sales and marketing — — — — General and administrative — 10 6 43 $ — $ 14 $ 6 $ 64

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Numerator: Net loss $ (2,085) $ (640) $ (8,598) $ (2,113) Less: preferred stock dividends (4) (4) (12) (23) Net loss attributable to common stockholders $ (2,089) $ (644) $ (8,610) $ (2,136) Denominator: Weighted-average number of shares of common stock for diluted net loss per share 5,257 5,184 5,237 5,128 Basic and diluted net loss per share $ (0.40) $ (0.12) $ (1.64) $ (0.42)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss): Nine Months Ended September 30, 2020 2019 Unvested restricted stock units — 23,334 Outstanding stock options 107,500 107,500 Unvested restricted stock awards 627 627 Shares of common stock issuable upon conversion of Series A-2 preferred stock 15,545 10,978 Shares of common stock issuable upon conversion of Series C preferred stock 83,333 158,333 Shares of common stock issuable upon conversion of Series D preferred stock 17,020,100 — Shares of common stock issuable upon conversion of Series E preferred stock 1,315,790 — Warrants 72,394 —

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information	Certain information concerning the Company’s segments for the three and nine months ended September 30, 2020 is presented in the following tables (in thousands): Three Months ended September 30, 2020 Glowpoint Oblong Industries Total Revenue $ 1,324 $ 1,942 $ 3,266 Cost of revenues 893 719 1,612 Gross profit $ 431 $ 1,223 $ 1,654 Gross profit % 33 % 63 % 51 % Allocated operating expenses $ 1,187 $ 1,477 $ 2,664 Unallocated operating expenses 980 Total operating expenses $ 1,187 $ 1,477 $ 3,644 Loss from operations $ (756) $ (254) $ (1,990) Interest and other expense, net 5 90 95 Net loss $ (761) $ (344) $ (2,085) Nine Months Ended September 30, Glowpoint Oblong Industries Total Revenue $ 4,741 $ 6,669 $ 11,410 Cost of revenues 2,948 2,736 5,684 Gross profit $ 1,793 $ 3,933 $ 5,726 Gross profit % 38 % 59 % 50 % Allocated operating expenses $ 3,398 $ 7,545 $ 10,943 Unallocated operating expenses 3,059 Total operating expenses $ 3,398 $ 7,545 $ 14,002 Loss from operations $ (1,605) $ (3,612) $ (8,276) Interest and other expense, net 12 310 322 Net loss $ (1,617) $ (3,922) $ (8,598) The disaggregation of the Company’s total assets as of September 30, 2020 is presented below (in thousands): As of September 30, 2020 Glowpoint Oblong Total Total assets $ 3,370 $ 23,872 $ 27,242 Concentration of revenues was as follows: Three Months Ended September 30, 2020 2019 Segment % of Revenue % of Revenue Customer A Glowpoint 20 % 26 % Customer B Oblong Industries 12 % — % Customer C Glowpoint * 25 % * The amount did not exceed 10% of the Company’s consolidated total revenues. Nine Months Ended September 30, 2020 2019 Segment % of Revenue % of Revenue Customer A Glowpoint 17 % 23 % Customer B Oblong Industries 19 % — % Customer C Glowpoint * 27 % * The amount did not exceed 10% of the Company’s consolidated total revenues. Concentration of accounts receivable was as follows: As of September 30, 2020 2020 2019 Segment % of Accounts Receivable % of Accounts Receivable Customer A Glowpoint 20 % 15 % Customer B Oblong Industries * — % Customer C Glowpoint * 51 % Customer E Oblong Industries 15 % — % * The amount did not exceed 10% of the Company’s consolidated total accounts receivable.
Revenue from External Customers by Geographic Areas	Revenue by geographic area is allocated as follows (in thousands): Three Months ended September 30, 2020 2019 Domestic $ 2,080 $ 1,571 Foreign 1,186 799 $ 3,266 $ 2,370 Nine Months Ended September 30, 2020 2019 Domestic $ 7,536 $ 5,042 Foreign 3,874 2,361 $ 11,410 $ 7,403
Schedule of Disaggregated Revenue Information	Disaggregated information for the Company’s revenue has been recognized in the accompanying condensed consolidated statements of operations and is presented below according to contract type (in thousands): Three Months ended September 30, 2020 % of Revenue 2019 % of Revenue Revenue: Glowpoint Video collaboration services $ 249 8 % $ 1,317 56 % Network services 1,028 31 % 969 41 % Professional and other services 47 1 % 84 4 % Total Glowpoint revenue $ 1,324 40 % $ 2,370 100 % Revenue: Oblong Industries Visual collaboration product offerings $ 1,686 52 % — — % Professional services — — % — — % Licensing 256 8 % — — % Total Oblong Industries revenue $ 1,942 60 % — — % Total revenue $ 3,266 100 % $ 2,370 100 % Nine Months Ended September 30, 2020 % of Revenue 2019 % of Revenue Revenue: Glowpoint Video collaboration services $ 1,847 16 % $ 4,335 59 % Network services 2,719 24 % 2,879 39 % Professional and other services 175 2 % 189 3 % Total Glowpoint revenue 4,741 42 % 7,403 100 % Revenue: Oblong Industries Visual collaboration product offerings 4,931 43 % — — % Professional services 898 8 % — — % Licensing 840 7 % — — % Total Oblong Industries revenue 6,669 58 % — — % Total revenue $ 11,410 100 % $ 7,403 100.00 %

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Balance Sheet Information	The following provides balance sheet information related to leases as of September 30, 2020 (in thousands): September 30, 2020 Assets Operating lease, right-of-use asset, net $ 1,665 Liabilities Current portion of operating lease liabilities $ 907 Operating lease liabilities, net of current portion 889 Total operating lease liabilities $ 1,796
Schedule of Future Minimum Rental Payments for Operating Leases	The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands): Remaining Lease Payments Remainder of 2020 $ 258 2021 968 2022 566 2023 116 Total lease payments $ 1,908 Effect of discounting (112) Total lease liability $ 1,796

Business Description and Sign_3

Business Description and Significant Accounting Policies (Details) $ in Thousands	Oct. 01, 2019segment	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)leasesegment	Sep. 30, 2019USD ($)
Accounting Policies [Abstract]
Number of operating segments | segment	1			2
Property, Plant and Equipment [Line Items]
Impairment charges - property and equipment | $		$ 117	$ 20	$ 126	$ 20
Number of leases exited				4
New York
Property, Plant and Equipment [Line Items]
Number of leases exited				1
Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives				three
Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives				ten years

Liquidity and Going Concern U_2

Liquidity and Going Concern Uncertainty (Details) - USD ($)	3 Months Ended						9 Months Ended		17 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Mar. 01, 2022	Dec. 31, 2019	Dec. 31, 2018
Line of Credit Facility [Line Items]
Cash	$ 2,670,000			$ 1,271,000			$ 2,670,000	$ 1,271,000		$ 4,602,000	$ 2,007,000
Long term debt	8,026,000						8,026,000			5,609,000
Working capital	(3,245,000)						(3,245,000)
Net loss	(2,085,000)	$ (3,385,000)	$ (3,129,000)	$ (640,000)	$ (875,000)	$ (598,000)	(8,598,000)	(2,113,000)
Net cash used in operating activities							(4,325,000)	$ (668,000)
Decrease in operating expenses			$ 1,813,000
Decrease in operating expenses, percentage			40.00%
Operating expenses	2,747,000		$ 4,560,000
Private Placement | Common Stock
Line of Credit Facility [Line Items]
Proceeds from issuance of stock							2,973,000
SVB loan agreement
Line of Credit Facility [Line Items]
Long term debt	5,609,000						5,609,000			5,609,000
Net cash used in operating activities							2,500,000
SVB loan agreement | Forecast
Line of Credit Facility [Line Items]
Principal payment									$ 291,500
PPP Loan
Line of Credit Facility [Line Items]
Long term debt	$ 2,417,000						$ 2,417,000			$ 0

Oblong Industries Acquisition -

Oblong Industries Acquisition - Additional Information (Details) - USD ($) $ in Thousands	Oct. 01, 2019	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2018
Business Acquisition [Line Items]
Goodwill		$ 7,366	$ 7,366	$ 7,907	$ 2,795
Oblong Industries
Business Acquisition [Line Items]
Purchase price	$ 18,862
Assets acquired	11,496
Intangible assets acquired	12,780
Goodwill	$ 7,366	7,366	7,366
Revenue from acquiree		1,942	6,669
Net losses from acquiree		$ 334	$ 3,839

Oblong Industries Acquisition_2

Oblong Industries Acquisition - Pro Forma (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Total revenue	$ 6,629	$ 20,161
Pro forma net loss	4,396	14,895
Oblong Industries
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Total revenue	4,259	12,758
Pro forma net loss	3,756	12,782
Glowpoint
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Total revenue	2,370	7,403
Pro forma net loss	$ 640	$ 2,113

Inventory (Details)

Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Inventory	$ 1,126	$ 1,816

Goodwill - Narrative (Details)

Goodwill - Narrative (Details) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2020USD ($)reporting_unit	Sep. 30, 2019USD ($)	Dec. 31, 2019USD ($)	Oct. 01, 2019USD ($)	Dec. 31, 2018USD ($)
Goodwill [Line Items]
Goodwill	$ 7,366		$ 7,907		$ 2,795
Number of reporting units | reporting_unit	2
Impairment charges - goodwill	$ 541	$ 453	2,254
Glowpoint
Goodwill [Line Items]
Goodwill	0		541	$ 541	$ 2,795
Impairment charges - goodwill	541	$ 453	$ 2,254
Oblong Industries
Goodwill [Line Items]
Goodwill	$ 7,366			$ 7,366

Goodwill - Schedule of Goodwill

Goodwill - Schedule of Goodwill (Details) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Goodwill [Roll Forward]
Beginning balance	$ 7,907	$ 2,795	$ 2,795
Impairment charges	(541)	(453)	(2,254)
Acquisition			7,366
Ending balance	7,366		7,907
Glowpoint
Goodwill [Roll Forward]
Beginning balance	541	2,795	2,795
Impairment charges	(541)	(453)	(2,254)
Acquisition			0
Ending balance	0		541
Oblong Industries
Goodwill [Roll Forward]
Beginning balance	7,366	$ 0	0
Impairment charges	0		0
Acquisition			7,366
Ending balance	$ 7,366		$ 7,366

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Business Acquisition [Line Items]
Gross Carrying Amount	$ 18,657	$ 18,657
Accumulated Amortization	(7,920)	(6,085)
Net Carrying Amount	10,737	12,572
Glowpoint
Business Acquisition [Line Items]
Gross Carrying Amount	5,877	5,877
Accumulated Amortization	(5,601)	(5,505)
Net Carrying Amount	276	372
Glowpoint | Customer Relationships
Business Acquisition [Line Items]
Gross Carrying Amount	4,335	4,335
Accumulated Amortization	(4,335)	(4,335)
Net Carrying Amount	0	0
Glowpoint | Affiliate network
Business Acquisition [Line Items]
Gross Carrying Amount	994	994
Accumulated Amortization	(718)	(666)
Net Carrying Amount	$ 276	328
Estimated Useful Life	12 years
Glowpoint | Trademarks
Business Acquisition [Line Items]
Gross Carrying Amount	$ 548	548
Accumulated Amortization	(548)	(504)
Net Carrying Amount	$ 0	44
Estimated Useful Life	8 years
Oblong Industries
Business Acquisition [Line Items]
Gross Carrying Amount	$ 12,780	12,780
Accumulated Amortization	(2,319)	(580)
Net Carrying Amount	10,461	12,200
Oblong Industries | Customer Relationships
Business Acquisition [Line Items]
Gross Carrying Amount	310	310
Accumulated Amortization	(62)	(16)
Net Carrying Amount	$ 248	294
Estimated Useful Life	5 years
Oblong Industries | Developed technology
Business Acquisition [Line Items]
Gross Carrying Amount	$ 10,060	10,060
Accumulated Amortization	(2,016)	(504)
Net Carrying Amount	$ 8,044	9,556
Estimated Useful Life	5 years
Oblong Industries | Trade names
Business Acquisition [Line Items]
Gross Carrying Amount	$ 2,410	2,410
Accumulated Amortization	(241)	(60)
Net Carrying Amount	$ 2,169	$ 2,350
Estimated Useful Life	10 years

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Business Acquisition [Line Items]
Impairment charges	$ 0		$ 0
Amortization expense	$ 611	$ 32	$ 1,835	$ 95
Minimum
Business Acquisition [Line Items]
Intangible assets, estimated useful life			5 years
Maximum
Business Acquisition [Line Items]
Intangible assets, estimated useful life			12 years

Intangible Assets - Schedule _2

Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2020	$ 597
2021	2,388
2022	2,386
2023	2,378
2024	1,844
Thereafter	1,144
Net Carrying Amount	$ 10,737	$ 12,572

Accrued Expenses and Other Li_3

Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Other Liabilities Disclosure [Abstract]
Accrued compensation costs	$ 627	$ 810
Other accrued expenses and liabilities	858	843
Accrued dividends on Series A-2 Preferred Stock	4	99
Accrued expenses and other liabilities	$ 1,489	$ 1,752

Debt - Schedule of Long-term De

Debt - Schedule of Long-term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Long term debt	$ 8,026	$ 5,609
Net carrying value	7,977	5,507
Current portion of long-term debt, net of discount	4,942	2,664
Long-term debt, excluding current maturities	3,035	2,843
SVB loan agreement
Debt Instrument [Line Items]
Long term debt	5,609	5,609
Less: Unamortized SVB debt discount	(49)	(102)
Current portion of long-term debt, net of discount	3,465	2,664
Long-term debt, excluding current maturities	2,095	2,843
PPP Loan
Debt Instrument [Line Items]
Long term debt	2,417	0
Current portion of long-term debt, net of discount	1,477	0
Long-term debt, excluding current maturities	$ 940	$ 0

Debt (Details) - Schedule of Ma

Debt (Details) - Schedule of Maturities of Long-term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Remainder of 2020	$ 1,143
2021	5,109
2022	1,774
Total future minimum payments	8,026	$ 5,609
SVB loan agreement
Debt Instrument [Line Items]
Remainder of 2020	874
2021	3,498
2022	1,237
Total future minimum payments	5,609	5,609
PPP Loan
Debt Instrument [Line Items]
Remainder of 2020	269
2021	1,611
2022	537
Total future minimum payments	$ 2,417	$ 0

Debt - SVB Agreement (Details)

Debt - SVB Agreement (Details)	3 Months Ended	9 Months Ended		17 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Mar. 01, 2022USD ($)	Apr. 10, 2020installment	Dec. 31, 2019USD ($)	Oct. 01, 2019USD ($)$ / sharesshares
Debt Instrument [Line Items]
Outstanding principal, debt obligations	$ 8,026,000	$ 8,026,000				$ 5,609,000
Amortization of debt discount		53,000	$ 0
SVB loan agreement
Debt Instrument [Line Items]
Outstanding principal, debt obligations	5,609,000	5,609,000				5,609,000
Unamortized debt discount	49,000	49,000				102,000
SVB loan agreement | Forecast
Debt Instrument [Line Items]
Principal payment				$ 291,500
Period of installments				18 months
PPP Loan
Debt Instrument [Line Items]
Outstanding principal, debt obligations	2,417,000	2,417,000				$ 0
Fixed rate					1.00%
Number of monthly installments | installment					18
Additional Paid-In Capital
Debt Instrument [Line Items]
Issuance of warrants to purchase common stock in connection with long term debt		72,000
SVB Warrant
Debt Instrument [Line Items]
Number of warrants called | shares							72,394
Exercise price (in dollars per share) | $ / shares							$ 0.01
Warrant term							10 years
Term loan facility | SVB loan agreement
Debt Instrument [Line Items]
Face amount							$ 5,247,000
Effective percentage						6.75%
Fee amount							192,000
Debt issuance costs							20,000
Amortization of debt discount	8,000
Unamortized debt discount	$ 49,000	$ 49,000				$ 102,000
Term loan facility | SVB loan agreement | Prime rate
Debt Instrument [Line Items]
Basis spread		2.00%
Term loan facility | SVB Loan Agreement, Amendment
Debt Instrument [Line Items]
Effective percentage	7.50%	7.50%
Term loan facility | SVB Loan Agreement, Amendment | Prime rate
Debt Instrument [Line Items]
Basis spread		4.25%
Term loan facility | Deferral fee | SVB Loan Agreement, Amendment
Debt Instrument [Line Items]
Fee amount							100,000
Term loan facility | Maturity Fee | SVB loan agreement
Debt Instrument [Line Items]
Fee amount							$ 262,000

Preferred Stock (Details)

Preferred Stock (Details) - USD ($)	Oct. 01, 2019	Jan. 25, 2018	Nov. 12, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Dec. 31, 2019	Jan. 31, 2018
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)				5,000,000					5,000,000
Accrued dividends on Series A-2 Preferred Stock				$ 4,000					$ 4,000	$ 99,000
Common stock, shares outstanding (in shares)				5,242,558					5,242,558	5,161,543
Common Stock
Class of Stock [Line Items]
Shares issued in conversion (in shares)									15,625
Conversion of convertible preferred stock, shares (in shares)				25,000		50,000		43,402
Issuance of restricted stock (in shares)					23,334		65,000	16,824
Common Stock | Subsequent Event
Class of Stock [Line Items]
Shares issued in conversion (in shares)			18,131
Number of shares issued (in shares)			1,043,000
Sale of stock, price per share (in dollars per share)			$ 2.85
Restricted stock
Class of Stock [Line Items]
Vesting period									10 years
Perpetual Series B-1 Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)				100					100
Preferred stock, shares issued (in shares)				0					0
Preferred stock, shares outstanding (in shares)				0					0
Series A-2 Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)				7,500					7,500	7,500
Preferred stock, shares issued (in shares)				45					45	32
Preferred stock, shares outstanding (in shares)				45					45	32
Preferred stock percentage									5.00%
Preferred stock, stated value				$ 7,500					$ 7,500	$ 7,500
Stock issued during period, conversion of convertible securities, price (in dollars per share)				$ 21.60					$ 21.60
Convertible preferred stock, shares issued upon conversion (in shares)				345					345
Accrued dividends on Series A-2 Preferred Stock				$ 4,000					$ 4,000	$ 99,000
Conversion of convertible preferred stock, shares (in shares)									13
Redemption price per share (in dollars per share)				$ 8,250					$ 8,250
Redemption price per share, multiplier (in dollars per share)				$ 7,500					$ 7,500
Redemption price per share, multiplier, percentage				110.00%					110.00%
Conversion price below the fair value of common stock (in dollars per share)									$ 11.16
Preferred stock, convertible, par value (in dollars per share)				$ 0.0001					$ 0.0001	$ 0.0001
Series A-2 Preferred Stock | Subsequent Event
Class of Stock [Line Items]
Stock issued during period, conversion of convertible securities, price (in dollars per share)			$ 18.49
Convertible preferred stock, shares issued upon conversion (in shares)			405
Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)				2,800					2,800
Preferred stock, shares issued (in shares)				0					0
Preferred stock, shares outstanding (in shares)				0					0
Preferred stock percentage									0.00%
Series B Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)								75
Series C Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)				1,750					1,750	1,750
Preferred stock, shares issued (in shares)				250					250	475
Preferred stock, shares outstanding (in shares)				250					250	475
Preferred stock percentage									0.00%
Preferred stock, stated value				$ 1,000					$ 1,000	$ 1,000
Stock issued during period, conversion of convertible securities, price (in dollars per share)											$ 3
Proceeds from issuance of preferred stock gross		$ 1,750,000
Preferred stock, convertible, par value (in dollars per share)		$ 1,000		$ 0.0001					$ 0.0001	$ 0.0001
Series C Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)				75		150		50	225	50
Series C Preferred Stock | Common Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)									75,000	16,667
Series D Convertible Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)				4,000					4,000
Preferred stock, shares issued (in shares)				0					0
Preferred stock, shares outstanding (in shares)				0					0
Perpetual Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)				100					100
Preferred stock, shares issued (in shares)				0					0
Preferred stock, shares outstanding (in shares)				0					0
Series D Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)				1,750,000					1,750,000	1,750,000
Preferred stock, shares issued (in shares)				1,702,010					1,702,010	1,734,901
Preferred stock, shares outstanding (in shares)				1,702,010					1,702,010	1,734,901
Preferred stock percentage									6.00%
Preferred stock, stated value				$ 28.50			$ 2.85		$ 28.50	$ 28.50
Conversion of convertible preferred stock, shares (in shares)									1,686,659
Preferred stock, convertible, par value (in dollars per share)				$ 0.0001					$ 0.0001	$ 0.0001
Series D Preferred Stock | Common Stock
Class of Stock [Line Items]
Common stock, shares outstanding (in shares)				5,242,558					5,242,558
Series D Preferred Stock | Restricted stock
Class of Stock [Line Items]
Issuance of restricted stock (in shares)	49,967								49,967
Vesting period	2 years
Series E Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)				175,000					175,000	175,000
Preferred stock, shares issued (in shares)				131,579					131,579	131,579
Preferred stock, shares outstanding (in shares)				131,579					131,579	131,579
Preferred stock percentage									6.00%
Preferred stock, stated value				$ 28.50					$ 28.50	$ 28.50
Preferred stock, convertible, par value (in dollars per share)				$ 0.0001					$ 0.0001	$ 0.0001
Series E Preferred Stock | Common Stock
Class of Stock [Line Items]
Common stock, shares outstanding (in shares)				23,578,448					23,578,448
Series E Preferred Stock | Series E Financing
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)				131,579					131,579
Convertible preferred stock, shares issued upon conversion (in shares)				17,020,100					17,020,100
Sale of stock, price per share (in dollars per share)	$ 2.85
Sale of stock consideration received	$ 3,750,000								$ 3,750,000
Series E Preferred Stock | Series E Financing | Maximum
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)	1,315,790

Stock Based Compensation - Narr

Stock Based Compensation - Narrative (Details) - USD ($)	Oct. 01, 2019	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 19, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options outstanding (in shares)		107,500		107,500		215,345		118,003
Number of options granted (in shares)						107,845
Stock option compensation expense		$ 0	$ 14,000	$ 6,000	$ 64,000
Options, intrinsic value, vested		0		0
Unrecognized stock-based compensation expense for stock options		$ 0		0
Stock-based compensation, tax benefit				0		$ 0
Compensation costs capitalized as part of the cost of an asset				$ 0
Weighted average period for amortization of unrecognized stock-based compensation				1 year
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted (in shares)				0
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares)		627		627		627		11,320
Stock option compensation expense		$ 0	0	$ 0	$ 3,000
Vesting period				10 years
Award service period				5 years
Unrecognized stock-based compensation expense for other than options		$ 0		$ 0
Granted, restricted shares (in shares)						0
Forfeited, restricted shares (in shares)						9,321
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares)		0		0		23,334		503,518
Unrecognized stock-based compensation expense for other than options		$ 0		$ 0
Stock-based compensation arrangement, vested in period, remain outstanding (in shares)				28,904
Granted, restricted shares (in shares)					55,479
Forfeited, restricted shares (in shares)					421,158
Series D Preferred Stock | Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares)		5,123		5,123
Stock option compensation expense		$ 28,000	$ 0	$ 83,000	$ 0
Vesting period	2 years
Unrecognized stock-based compensation expense for other than options		$ 57,000		$ 57,000
Issuance of restricted stock (in shares)	49,967			49,967
Forfeited, restricted shares (in shares)		1,086		32,891
Nonemployee | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)	107,845
Weighted average price of shares (in dollars per share)	$ 4.92
Exercise period	1 year
Stock option compensation expense		$ 0		$ 0
Prior plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)							421,000
2019 Equity incentive plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)		3,021,000		3,021,000
Awards granted in period (in shares)				0
2019 Equity incentive plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)		2,600,000		2,600,000
2007 Stock incentive plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)		0		0
2007 Stock incentive plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options outstanding (in shares)		107,500		107,500
2007 Stock incentive plan | Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares)		627		627

Stock Based Compensation - Opti

Stock Based Compensation - Options Outstanding (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2020$ / sharesshares	Dec. 31, 2019$ / sharesshares
Number of Options
Outstanding Number of Options, Beginning (in shares) | shares	215,345	118,003
Outstanding Number of Options, Exchanged for Oblong Industries stock options (in shares) | shares		107,845
Outstanding Number of Options, Expired (in shares) | shares	(107,845)	(440)
Forfeited restricted stock (in shares) | shares		(10,063)
Outstanding and Exercisable Number of Options, Ending (in shares) | shares	107,500	215,345
Weighted Average Exercise Price
Outstanding Weighted Average Exercise Price, Beginning (in dollars per share) | $ / shares	$ 12.27	$ 19.90
Outstanding Weighted Average Exercise Price, Exchanged for Oblong Industries stock options (in dollars per share) | $ / shares		4.92
Outstanding Weighted Average Exercise Price, Expired (in dollars per share) | $ / shares	4.92	16.48
Outstanding Weighted Average Exercise Price, Forfeited (in dollars per share) | $ / shares		23.20
Outstanding and Exercisable Weighted Average Exercise Price, Ending (in dollars per share) | $ / shares	$ 19.64	$ 12.27
Exercisable
Exercisable Number of Options (in shares) | shares	107,500
Exercisable Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 19.64

Stock Based Compensation - Exer

Stock Based Compensation - Exercise Price Range (Details) - $ / shares	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2018
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options, Outstanding and Exercisable (in shares)	107,500	215,345	118,003
Weighted Average Remaining Contractual Life (In Years)	2 years 3 months 3 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 19.64	$ 12.27	$ 19.90
$0.00 – $10.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	0
Range of price, upper range limit (in dollars per share)	$ 10
Number of Options, Outstanding and Exercisable (in shares)	2,500
Weighted Average Remaining Contractual Life (In Years)	2 years 8 months 12 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 9
$10.01 – $20.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	10.01
Range of price, upper range limit (in dollars per share)	$ 20
Number of Options, Outstanding and Exercisable (in shares)	97,500
Weighted Average Remaining Contractual Life (In Years)	2 years 3 months 21 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 19.32
$20.01 – $30.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	20.01
Range of price, upper range limit (in dollars per share)	$ 30
Number of Options, Outstanding and Exercisable (in shares)	2,500
Weighted Average Remaining Contractual Life (In Years)	1 year 8 months 4 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 21.80
$30.01 – $40.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	30.01
Range of price, upper range limit (in dollars per share)	$ 40
Number of Options, Outstanding and Exercisable (in shares)	5,000
Weighted Average Remaining Contractual Life (In Years)	1 year 5 months 12 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 30.20

Stock Based Compensation - Rest

Stock Based Compensation - Restricted Stock Activity (Details) - Restricted stock - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Restricted Shares
Unvested restricted shares outstanding, Beginning (in shares)	627	11,320
Granted, restricted shares (in shares)		0
Vested, restricted shares (in shares)		(1,372)
Forfeited, restricted shares (in shares)		(9,321)
Unvested restricted shares outstanding, Ending (in shares)	627	627
Weighted Average Grant Date Price
Unvested restricted shares, weighted average grant price, Beginning (in dollars per share)	$ 15.80	$ 14.88
Granted, weighted average grant price (in dollars per share)		0
Vested, weighted average grant price (in dollars per share)		15.72
Forfeited, weighted average grant price (in dollars per share)		14.70
Unvested restricted shares, weighted average grant price, Ending (in dollars per share)	$ 15.80	$ 15.80

Stock Based Compensation - Stoc

Stock Based Compensation - Stock Compensation Expense, Restricted Stock (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 0	$ 14	$ 6	$ 64
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	10	6	43
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	0	0	3
Restricted stock | General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 0	$ 0	$ 0	$ 3

Stock Based Compensation - Re_2

Stock Based Compensation - Restricted Stock Unit Activity (Details) - RSUs - $ / shares	9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Restricted Stock Units
Unvested restricted shares outstanding, Beginning (in shares)	23,334	503,518	503,518
Granted, restricted shares (in shares)		55,479
Vested, restricted shares (in shares)	(23,334)	(114,505)
Forfeited, restricted shares (in shares)		(421,158)
Unvested restricted shares outstanding, Ending (in shares)	0		23,334
Weighted Average Grant Price
Unvested restricted shares, weighted average grant price, Beginning (in dollars per share)	$ 2.20	$ 1.94	$ 1.94
Granted, weighted average grant price (in dollars per share)		1.30
Vested, weighted average grant price (in dollars per share)	2.20	3.05
Forfeited, weighted average grant price (in dollars per share)		$ 1.54
Unvested restricted shares, weighted average grant price, Ending (in dollars per share)	$ 0		$ 2.20

Stock Based Compensation - St_2

Stock Based Compensation - Stock Compensation Expense, Restricted Stock Units (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 0	$ 14	$ 6	$ 64
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	2	0	10
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	2	0	11
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	0	0	0
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	10	6	43
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	0	0	3
Restricted stock | General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	0	0	3
Series D Preferred Stock | Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	28	0	83	0
Series D Preferred Stock | Restricted stock | Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	11	0	39	0
Series D Preferred Stock | Restricted stock | Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	7	0	17	0
Series D Preferred Stock | Restricted stock | General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 10	$ 0	$ 27	$ 0

Net Loss Per Share - Narrative

Net Loss Per Share - Narrative (Details)	9 Months Ended
	Sep. 30, 2020shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average shares common stock outstanding, potentially dilutive securities or unvested restricted stock (in shares)	0

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Numerator:
Net loss	$ (2,085)	$ (3,385)	$ (3,129)	$ (640)	$ (875)	$ (598)	$ (8,598)	$ (2,113)
Less: preferred stock dividends	(4)			(4)			(12)	(23)
Net loss attributable to common stockholders	$ (2,089)			$ (644)			$ (8,610)	$ (2,136)
Denominator:
Weighted-average number of shares of common stock for diluted net loss per share (in shares)	5,257			5,184			5,237	5,128
Basic and diluted net loss per share (in dollars per share)	$ (0.40)			$ (0.12)			$ (1.64)	$ (0.42)

Net Loss Per Share - Effect of

Net Loss Per Share - Effect of Antidilutive Securities (Details) - shares	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Unvested restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	23,334
Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	107,500	107,500
Unvested restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	627	627
Series A-2 Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	15,545	10,978
Series C Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	83,333	158,333
Series D Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	17,020,100	0
Series E Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,315,790	0
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	72,394	0

Segment Reporting (Details)

Segment Reporting (Details) $ in Thousands	Oct. 01, 2019segment	Sep. 30, 2020USD ($)	Jun. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Sep. 30, 2019USD ($)	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Sep. 30, 2020USD ($)segment	Sep. 30, 2019USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment	1							2
Revenue		$ 3,266			$ 2,370			$ 11,410	$ 7,403
Cost of revenues		1,612			1,582			5,684	4,901
Gross profit		$ 1,654			788			$ 5,726	2,502
Gross profit %		51.00%						50.00%
Total operating expenses		$ 3,644			1,428			$ 14,002	4,614
Loss from operations		(1,990)			(640)			(8,276)	(2,112)
Interest and other expense, net		95			0			322	1
Net loss		(2,085)	$ (3,385)	$ (3,129)	(640)	$ (875)	$ (598)	(8,598)	(2,113)
Glowpoint
Segment Reporting Information [Line Items]
Revenue		1,324			2,370			4,741	7,403
Cost of revenues		893						2,948
Gross profit		$ 431						$ 1,793
Gross profit %		33.00%						38.00%
Total operating expenses		$ 1,187						$ 3,398
Loss from operations		(756)						(1,605)
Interest and other expense, net		5						12
Net loss		(761)						(1,617)
Oblong Industries
Segment Reporting Information [Line Items]
Revenue		1,942			$ 0			6,669	$ 0
Cost of revenues		719						2,736
Gross profit		$ 1,223						$ 3,933
Gross profit %		63.00%						59.00%
Total operating expenses		$ 1,477						$ 7,545
Loss from operations		(254)						(3,612)
Interest and other expense, net		90						310
Net loss		(344)						(3,922)
Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses		2,664						10,943
Allocated operating expenses | Glowpoint
Segment Reporting Information [Line Items]
Total operating expenses		1,187						3,398
Allocated operating expenses | Oblong Industries
Segment Reporting Information [Line Items]
Total operating expenses		1,477						7,545
Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses		$ 980						3,059
Unallocated operating expenses | Glowpoint
Segment Reporting Information [Line Items]
Total operating expenses
Unallocated operating expenses | Oblong Industries
Segment Reporting Information [Line Items]
Total operating expenses

Segment Reporting - Disaggregat

Segment Reporting - Disaggregation of Revenue and Total Assets (Details) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Dec. 31, 2019USD ($)
Disaggregation of Revenue [Line Items]
Foreign revenue	0.01		0.01
Revenue	$ 3,266	$ 2,370	$ 11,410	$ 7,403
Total assets	$ 27,242		$ 27,242		$ 34,909
Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	100.00%	100.00%	100.00%	100.00%
Glowpoint
Disaggregation of Revenue [Line Items]
Revenue	$ 1,324	$ 2,370	$ 4,741	$ 7,403
Total assets	$ 3,370		$ 3,370
Glowpoint | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	40.00%	100.00%	42.00%	100.00%
Glowpoint | Assets
Disaggregation of Revenue [Line Items]
Percentage of revenue			100.00%		100.00%
Glowpoint | Video collaboration services
Disaggregation of Revenue [Line Items]
Revenue	$ 249	$ 1,317	$ 1,847	$ 4,335
Glowpoint | Video collaboration services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	8.00%	56.00%	16.00%	59.00%
Glowpoint | Network services
Disaggregation of Revenue [Line Items]
Revenue	$ 1,028	$ 969	$ 2,719	$ 2,879
Glowpoint | Network services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	31.00%	41.00%	24.00%	39.00%
Glowpoint | Professional and other services
Disaggregation of Revenue [Line Items]
Revenue	$ 47	$ 84	$ 175	$ 189
Glowpoint | Professional and other services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	1.00%	4.00%	2.00%	3.00%
Oblong Industries
Disaggregation of Revenue [Line Items]
Revenue	$ 1,942	$ 0	$ 6,669	$ 0
Total assets	$ 23,872		$ 23,872
Oblong Industries | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	60.00%	0.00%	58.00%	0.00%
Oblong Industries | Video collaboration services
Disaggregation of Revenue [Line Items]
Revenue	$ 1,686	$ 0	$ 4,931	$ 0
Oblong Industries | Video collaboration services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	52.00%	0.00%	43.00%	0.00%
Oblong Industries | Professional and other services
Disaggregation of Revenue [Line Items]
Revenue	$ 0	$ 0	$ 898	$ 0
Oblong Industries | Professional and other services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	0.00%	0.00%	8.00%	0.00%
Oblong Industries | Licensing
Disaggregation of Revenue [Line Items]
Revenue	$ 256	$ 0	$ 840	$ 0
Oblong Industries | Licensing | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	8.00%	0.00%	7.00%	0.00%
Domestic
Disaggregation of Revenue [Line Items]
Revenue	$ 2,080	$ 1,571	$ 7,536	$ 5,042
Domestic | Oblong Industries | Assets
Disaggregation of Revenue [Line Items]
Percentage of revenue			88.00%
Foreign
Disaggregation of Revenue [Line Items]
Revenue	$ 1,186	$ 799	$ 3,874	$ 2,361
Foreign | Oblong Industries | Assets
Disaggregation of Revenue [Line Items]
Percentage of revenue			12.00%

Segment Reporting - Concentrati

Segment Reporting - Concentration Percentage (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue
Concentration Risk [Line Items]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Glowpoint | Revenue
Concentration Risk [Line Items]
Concentration risk percentage	40.00%	100.00%	42.00%	100.00%
Oblong Industries | Revenue
Concentration Risk [Line Items]
Concentration risk percentage	60.00%	0.00%	58.00%	0.00%
Customer A | Glowpoint | Revenue
Concentration Risk [Line Items]
Concentration risk percentage	20.00%	26.00%	17.00%	23.00%
Customer A | Glowpoint | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage			20.00%	15.00%
Customer B | Oblong Industries | Revenue
Concentration Risk [Line Items]
Concentration risk percentage	12.00%	0.00%	19.00%	0.00%
Customer B | Oblong Industries | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage				0.00%
Customer C | Glowpoint | Revenue
Concentration Risk [Line Items]
Concentration risk percentage		25.00%		27.00%
Customer C | Glowpoint | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage				51.00%
Customer E | Oblong Industries | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage			15.00%	0.00%

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)lease	Sep. 30, 2019USD ($)	Sep. 01, 2020USD ($)	Jun. 30, 2020USD ($)	Dec. 31, 2019USD ($)	Oct. 01, 2019USD ($)	Jan. 01, 2019USD ($)
Lessee, Lease, Description [Line Items]
Non-cash lease expense	$ 267		$ 52	$ 915	$ 153
Operating lease - right of use asset, net	1,665			1,665				$ 3,117
Operating lease liability	1,796			$ 1,796
Number of leases exited | lease				4
Disposal of ROU assets and operating lease liability		$ 214
Revenue	3,266		$ 2,370	$ 11,410	$ 7,403
Professional and other services | Major customer
Lessee, Lease, Description [Line Items]
Revenue				$ 1,000
Concentration risk percentage				9.00%
Los Angeles Warehouse Lease
Lessee, Lease, Description [Line Items]
ROU disposal							$ 317
Lease liability disposal							$ 333
Atlanta Lease
Lessee, Lease, Description [Line Items]
ROU disposal	18			$ 18
Lease liability disposal	21			$ 21
Contract termination fee	10
New York
Lessee, Lease, Description [Line Items]
Number of leases exited | lease				1
London
Lessee, Lease, Description [Line Items]
Number of leases exited | lease				1
Altlanta
Lessee, Lease, Description [Line Items]
Number of leases exited | lease				1
Los Angeles
Lessee, Lease, Description [Line Items]
Term of contract						18 months
Operating lease - right of use asset, net						$ 116
Operating lease liability						$ 116
Number of leases entered | lease				1
Number of leases exited | lease				1
Calculation error | Adjustment
Lessee, Lease, Description [Line Items]
Operating lease - right of use asset, net	195			$ 195
Operating lease liability	$ 195			$ 195
Accounting standards update 2016-02
Lessee, Lease, Description [Line Items]
Operating lease - right of use asset, net									$ 3,376	$ 99
Operating lease liability									$ 3,578	$ 111
Incremental borrowing rate									6.00%	7.75%
Minimum
Lessee, Lease, Description [Line Items]
Term of contract	1 year			1 year
Renewal term	12 months			12 months
Maximum
Lessee, Lease, Description [Line Items]
Term of contract	4 years			4 years
Renewal term	5 years			5 years

Commitments and Contingencies_2

Commitments and Contingencies - Balance Sheet Information (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Operating lease, right-of-use asset, net	$ 1,665	$ 3,117
Current portion of operating lease liabilities	907	1,294
Operating lease liabilities, net of current portion	889	$ 2,020
Total operating lease liabilities	$ 1,796

Commitments and Contingencies_3

Commitments and Contingencies - Table Operating Lease Future Minimum Rental Commitment (Details) $ in Thousands	Sep. 30, 2020USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of 2020	$ 258
2021	968
2022	566
2023	116
Total lease payments	1,908
Effect of discounting	(112)
Total lease liability	$ 1,796

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Thousands	Oct. 22, 2020	Oct. 21, 2020	Nov. 12, 2020	Sep. 30, 2020
Subsequent Event | SVB loan agreement
Subsequent Event [Line Items]
Payment extinguishment of debt	$ 2,500
Common Stock | Private Placement
Subsequent Event [Line Items]
Proceeds from issuance of stock				$ 2,973
Common Stock | Subsequent Event
Subsequent Event [Line Items]
Number of shares issued (in shares)			1,043,000
Common Stock | Subsequent Event | Private Placement
Subsequent Event [Line Items]
Number of shares issued (in shares)		1,043,000
Common stock, share price		$ 2.85
Proceeds from issuance of stock		$ 2,973
Warrants | Subsequent Event | Private Placement
Subsequent Event [Line Items]
Number of shares issued (in shares)		521,500

Uncategorized Items - glow-2020

Label	Element	Value
Inventory Write-down	us-gaap_InventoryWriteDown	$ 0